Acad. Prof. univ. dr. Dragoş MARINESCU

Member of the Romanian Academy of Medical Sciences

Deputy chief editor of The Romanian Journal of Psychiatry, the official publication of Romanian Psychiatric  and Psychotherapy Association.

Former President of the Pediatric Psychiatry and Psychiatry Commission of the Ministry of Health

Professor at University of Medicine and Pharmacy of Craiova , doctoral supervisor

 

 

CURRICULUM VITAE

 

  1. PROFESSIONAL EXPERIENCE

Period 2015 – present

Member of the Academy of Medical Sciences

Period 2005 – present

Deputy chief editor of The Romanian Journal of Psychiatry, the official publication of Romanian Psychiatric  and Psychotherapy Association.

Period 2009 – 2015

Occupation or position held: President of the Pediatric Psychiatry and Psychiatry Commission of the Ministry of Health

Main activities and responsibilities: Methodological coordination of national activities in the field of psychiatry

Name and address of employer: Ministry of Health

Type of business or sector: Public administration

Period 1991 – present

Occupation or position held: University professor; doctoral supervisor

Main activities and responsibilities: Teaching activity; research; PhD guidance; continuing medical education

Name and address of employer: University of Medicine and Pharmacy of Craiova

Type of business or sector: Higher Medical Education.

Period 2009 – 2010

Occupation or position held: Member Transparency Commission of the Ministry of Health

Main Activities and Responsibilities: Methodological Coordination of Activities Specific to National Psychiatric Assistance

Name and address of employer: Ministry of Health

Type of business or sector: Public administration

Period 2008 – 2011

Occupation or position held: Chief of Department 13 (Psychiatry, Neurology, Neurosurgery, Medical Psychology, General Psychology, Psychology of Development, Medical Sociology, Behavioral Sciences, Legal Medicine, Ophthalmology)

Main activities and responsibilities: Coordinating department; scientific research; continuing postgraduate medical education

Name and address of employer: University of Medicine and Pharmacy of Craiova

Type of business or sector: Higher Medical Education.

Period 2000 – 2004

Occupation or position held: Prodecan Faculty of Medicine

Main activities and responsibilities: Coordination of educational activity, scientific research, organization of disciplines

Name and address of employer: University of Medicine and Pharmacy of Craiova

Type of business or sector: Higher Medical Education.

Period 1991 – present

Occupation or position held: Senior psychiatrist

Main activities and responsibilities: Specialized medical assistance; medical research

Name and address of employer: Clinical Neuropsychiatry Hospital Craiova

Type of business or sector: Health

Period 1999 – 2000

Occupation or position held: General manager (founder of the hospital)

Main activities and responsibilities: Coordination and management of the sanitary unit; the achievement of the objectives set out in the national specific assistance programs in the field of psychiatry and neurology:

Name and address of employer: Clinical Neuropsychiatry Hospital Craiova

Type of business or sector: Health

Period 1997 – 1999

Occupation or position held: General Manager

Main activities and responsibilities: Coordination and management of the sanitary unit; the achievement of the objectives set out in the specific national assistance programs in the field of psychiatry, neurology, infectious diseases, HIV, TB.

Name and address of employer: Clinical Hospital Nr. 3 Victor Babes Craiova

Type of business or sector: Health

Period 1978 – 1991

Occupation or position held Psychiatrist specialist

Main activities and responsibilities Specialized medical assistance; medical research

Name and address of employer Clinical Hospital Nr. 3 Victor Babes Craiova – Psychiatric Section of Podari

Type of business or sector Health

Period 1975 – 1978

Occupation or position held: Secondary psychiatrist

Main activities and responsibilities: Specialized medical assistance; specialized training

Name and address of employer: Hospital Nr. 9 Gheorghe Marinescu Bucharest (currently Alexandru Obregia Clinical Hospital)

Type of business or sector Health

Period 1972 – 1975

Occupation or position held: Trainee physician psychiatrist

Main activities and responsibilities: Specialized medical assistance; specialized training; forensic psychiatry

Name and address of employer: Hospital Psychiatry City Dr. Petru Groza (now Ştei) Bihor County

Type of business or sector: Health

 

  1. PUBLISHED BOOKS AND CHAPTERS IN BOOKS OF SPECIALTY:
  2. Marinescu D, Mihaescu C. Moderate Psychotropic Medication – Therapeutic Guide. Ed. ACSA Craiova, 1996; 973-96228-6-0, 252 pages, A5.
  3. Marinescu D. Modern treatment of schizophrenia and affective psychoses – Actualities. AIUS Publishing House, Craiova, 1997 (monograph), ISBN 973-9251-24-2, 360 pag, A4.
  4. Udriştoiu T, Marinescu D, Gheorghe MD. Psychopharmacological Therapy – News. Scorilo Publishing House, Craiova, 2000, ISBN 973-99694-4-5, 146 pag, A4.
  5. Udriştoiu T, Marinescu D, Boisteanu P. Therapeutic Guide – Major Depression. Medical Publishing House Universitaria, Craiova, 2001,973-85008-5-0, 82 pag., B5.
  6. Marinescu D, Udriştoiu T, Chiriţă A. Therapeutic Guide – Schizophrenia. Publishing Medical University, Craiova, 2001, 973-85008-4-2, 86 pages, B5.
  7. Gheorghe MD, Marinescu D, Udriştoiu T. Therapeutic Guide – Bipolar Disorder. Medical Publishing House Universitaria, Craiova, 2001,973-85008-65-9, 58 pag., B5.
  8. Udriştoiu T, Marinescu D (under red.). Therapy and Management in Psychiatry. University Medical Publishing House, Craiova, 2001, 973-85009-8-2, 328 pag., A5.
  9. Udriştoiu T, Marinescu D (under red.). Therapy and Management in Psychiatry. Vol. II, Universitary Medical Publishing House, Craiova, 2001, 973-85008-3-4, 304 pag., A5.
  10. Marinescu D, Udriştoiu T. Neurobiological facts. Colinergic Mechanisms. Psychopharmacological and Therapeutic Considerations, Hippocratic Collection, Aius Publishing House, Craiova, 2004, 973-700-027-7, 148 pag, A5.
  11. Gheorghe MD, Marinescu D. Alzheimer’s Disease – Clinical and therapeutic etiopathogenic bases. University Press, Bucharest, 2005. 973-731-136-1, 136 pages, A5.
  12. Gheorghe MD, Marinescu D, Voicu VA. Antipsychotics. The Romanian Academy Publishing House, Bucharest, 2006., 973-27-1325-9, 156 pages, B3.
  13. Zăvoi R, Udriştoiu T, Marinescu D. Elements of Medico-Legal Psychiatry, University Medical Publishing House, Craiova, 2007, 978-973-106-046-0, 240 pages, B3.
  14. Cornutiu G, Marinescu D (under red.). Origins and Perspectives in Current Romanian Psychiatric Thought (vol. 1), University Publishing House of Oradea, 2007, 978-973-759-323-8, 460 pag., A5.
  15. Marinescu D. Neurobiological Reconsiderations in Etiopathogenesis and Treatment of Schizophrenia, Ed. Aius, Craiova, 2007, 978-973-1780-28-3, 120 pages, A5.
  16. Cornutiu G, Marinescu D (under red.). Orientation and Perspectives in Current Romanian Psychiatric Thought (vol. II), University Publishing House of Oradea, 2008, 978-973-759-533-1, 386 pag., A5.
  17. Marinescu D, Udriştoiu T, Podea D, Ciucu A. Depressive and anxiety disorder. Actualities, Aius PrintEd Publishing House, Craiova 2008, 978-973-1780-97-9, 369 pag., A5.
  18. Marinescu D, Udriştoiu T, Dehelean P. Neurobiological and nonbiological elements in antipsychotic treatment, Aius PrintEd Publishing House, Craiova 2009, 978-606-8021-43-0, 236 pag., A5.
  19. Cornutiu G, Marinescu D (under red.). Origins and Perspectives in Current Romanian Psychiatric Thought (volume III), University of Oradea Publishing House, 2009, A5
  20. Marinescu D, Udriştoiu T, Mogoantul L. Elements of biological psychiatry in clinical psychopharmacology, Aius PrintEd Publishing House, Craiova, 2010, ISBN 978-606-562-015-5, 124 pages, A5.
  21. Cornutiu G, Marinescu D (under red.). Origins and Perspectives in Current Romanian Psychiatric Thought (volume IV), University of Oradea Publishing, 2010, ISBN 978-606-10-0129-3, 488 pag, A5.
  22. Cornutiu G, Marinescu D (under red.). Origins and Perspectives in Current Romanian Psychiatric Thought (vol. V), University Publishing House of Oradea, 2011, ISBN 978-606-10-0451-5, 308 pag, A5
  23. Prelipceanu D (coord.) Băjenaru O, Ladea M, Lăzărescu M, Marinescu D, Popescu CA, Şerbănescu Grigoroiu M – Clinical Psychiatry, Medical Publishing House Bucharest, 2011, ISBN 978-973-39-0719-0, B3.
  24. Udristoiu T, Marinescu D (under red.). Pharmacological Therapy Guidelines in Major Psychiatric Disorders, Publishing House, Craiova, 2012, ISBN 978-973-106-179-5, 247 pag, B3.
  25. Marinescu D (coord.), Udriştoiu T, Prelipceanu D, Scripcaru C. Training curricula for assessing the work capacity of persons diagnosed with mental health problems (Educational support according to the provisions of the National Mental Health Program). 3.1 of prophylaxis in psychiatric and psychosocial pathology), Sedcom Libris Publishing House, Iasi, 2012, ISBN 978-973-670-466-6, 309 pag, B3.
  26. Cornuţiu G, Marinescu D (coord.) – Origins and Perspectives in Current Romanian Psychiatric Thought (vol. VI), University Publishing House of Oradea, 2013, ISBN 978-606-10-0906-0, pp. 261-278. , A5.
  27. Marinescu D (coord.), Marcian C, Bubulac V, Calinescu D, Scripcaru C. The training curriculum for nurses in the mental health system, Sedcom Libris Publishing House, Iasi, 2012, ISBN 978-973-670-495- 6, 281 pag, B4.
  28. Cornuţiu G, Marinescu D (coord.) – Origins and Perspectives in Current Romanian Psychiatric Thought (vol. VII), University Publishing House of Oradea, 2014, ISBN 978-606-101-3265, pp. 280-296., Pp 261-278., A5., Marinescu D. Factors influencing the evolution and prognosis of schizophrenia, pp. 280-296
  29. D. Marinescu, Ileana Marinescu, (coordonatori), Trecut, prezent si viitor in psihiatria Romaneasca, 2018 ISBN 979-606-562-736-9, Ed. Aius, Craiova, 436 pagini
  30. Marinescu Ileana, Marinescu D – Psihokinetoterapia în tratamentul schizofreniei, în Cornuţiu G, Marinescu D (coord.) – Orientări şi perspective în gândirea psihiatrică românească actuală (vol. IV), Editura Universităţii din Oradea, 2010, pp. 81-102.
  31. Ileana Marinescu – Deteriorarea cognitiva din boala Alzheimer are mecanisme patogenice comune cu schizofrenia? Pg 427-436, in volumul D. Marinescu, Ileana Marinescu, Trecut, prezent si viitor in psihiatria Romaneasca, 2018, ISBN 979-606-562-736-9, Ed. Aius, Craiova, 436 pagini
  32. Ileana Marinescu, D. Marinescu Trasaturile si tulburarile de personalitate – factori de predictie in deteriorarea cognitiva si comportamentala din boala Alzheimer, p 159-174 in volumul Persoana umana un model de diversitate antropologica, ISBN 978-973-169-523-5, 2018, Ed University Press, Tg. Mures, 273 pagini
  33. Ileana Marinescu, D. Marinescu, P.O. Stovicek, Modele neurobiologice diferentiate in tulburarea depresiva majora, p 40-50 in volumul Depresia si Schizofrenia, ISBN 978-973-169-532-7, University Press, Tg. Mures 2018, 144 pagini
  34. Ileana Marinescu, Dragoș Marinescu, Puiu Olivian Stovicek, Modificările de personalitate de tip lezional sau organic – Modele neurobiologice ale comportamentului agresiv în schizofrenie, p 9-38 in volumul Personalităţile patologice – determinism, comorbidităţi şi repere reabilitative, ISBN 978-973-169-652-2, University Press, Tg. Mures 2020, 228 pagini.
  35. PUBLISHED CHAPTERS IN INTERNATIONAL BOOKS OF SPECIALTY:
  36. Ileana Marinescu, P.O. Stovicek, D. Marinescu, L. Mogoanta, Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late- Onset Alzheimer’s Disease in Frontiers in Clinical Drug Research – Alzheimer Disorders Vol.8 eISBN: 978-981-14-0189-3, 2019, ISBN: 978-981-14-0190-9 ISSN: 2451-8743 (Print)  ISSN: 2214-5168 (Online)  DOI: 10.2174/97898114018931190801  Pp. 191-261 (71)
  37. Ileana Marinescu, Dragoș Marinescu, Liana Pauna-Cristian, Puiu Olivian Stovicek, Particularities of cerebral small vessel disease in schizophrenia, in Understanding and treating cerebral small vessel disease, Nova Science Publishers Inc, eISBN 978-1-53618-944-5, Pp 383-428.

 

  1. CHAPTERS IN IMPORTANT BOOKS (TREATISES);
  2. Chiriţă V, Papari A, Chiriţă R (under red.). Psychiatry Treaty, vol. II, Andrei Şaguna Foundation Publishing House, Constanţa, 2009, ISBN 978-973-732-105-3, Marinescu D, Udriştoiu T, Chiriţă A, Marinescu I. Clinical Psychopharmacology, 227-311, A4 .
  3. Chiriţă V, Papari A, Chiriţă R (under red.). Psychiatry Treaty, vol. II, Andrei Şaguna Foundation Publishing House, Constanţa, 2009, ISBN 978-973-732-105-3, Marinescu I, Marinescu D. Psycho-Therapy in the Treatment of Psychiatric Disorders, 389-406, A4.
  4. Hook V (under red.). Pharmacology, Vol. I, Ed. AIUS Craiova, 1998

Marinescu D, Udriştoiu T, Chiriţă A. “Antidepressants”, 231-255, Udriştoiu T, Marinescu D, Chiriţă A. “Neuroleptics”, 213-230, A4.

 

  1. COURSE SUPPORT FOR STUDENTS
  2. Udriştoiu T, Marinescu D (under red.). Psychiatry Course – General Medicine, Part I. Reprography of the University of Craiova, 1995;
  3. Udriştoiu T, Marinescu D (under red.). Psychiatry Course – General Medicine, Part II. Reprography of the University of Craiova, 1995;
  4. Udriştoiu T, Marinescu D (under red.). Course of Psychiatry – Dentistry. Reprography of the University of Craiova, 1995;
  5. Udriştoiu T, Marinescu D (under red.). Psychiatric Guide to Dentistry. Reprography of the University of Craiova, 1995;
  6. Gheorghe MD, Marinescu D. Current orientations in psychopharmacology – Course – Part I, Amaltea Medical Publishing House, Bucharest, 2000.
  7. Gheorghe MD, Marinescu D. Current orientations in psychopharmacology – Course – Part II, Amaltea Medical Publishing House, Bucharest, 2000.

 

  1. EMCD PROGRAM WITH UMF CRAIOVA APPROVAL – ELECTRONIC SUPPORT COURSE
  2. Marinescu D, Marinescu I, Pîrlog M. Biological facts in the medical treatment of the depressive disorder, http://www.cursurimedicale.ro/cursuri. (18 EMC credits, according to Address 6174 / 09.10.2014)

 

  1. ARTICLES PUBLISHED IN JOURNALS INDEXED IN ISI WEB OF KNOWLEDGE

1.Marinescu I, Predescu A, Udristoiu T, Marinescu D. Comparative study of neuroprotective effect of tricyclics vs. trazodone on animal model of depressive disorder, Romanian Journal of Morphology and Embriology, 2012, 53, 2:397-400. Impact factor 0,620

2.Marinescu I, Udriştoiu I, Marinescu D. Choroid plexus calcification: clinical, neuroimaging and histopathological correlations in schizophrenia, Rom J Morphol Embryol, 2013, 54(2):365–369. Impact factor 0,723.

3.Udriştoiu I, Marinescu I, Pîrlog MC, Militaru F, Udriştoiu T, Marinescu D, Mutică M. The microvascular alterations in frontal cortex during treatment with antipsychotics: a post-mortem study. Rom J Morphol Embryol, 2016, 57(2):501–506. Impact factor 0,670

4.Ileana Marinescu, V R Enatescu, S M Ghelase, D Marinescu, Neurobiological arguments for a pathogenic multifactorial disconnective model of cognitive disorders from Alzheimer’s disease in elderly people , Rom J Morphol Embryol 2017, 58(4):1165–1173, ISSN (print) 1220–0522 , ISSN (online) 2066–8279. Impact factor 0,912.

5.Ileana Marinescu. P.O. Stovicek, D. Marinescu, M.T. Papacocea, M.C. Manea, E. Ionescu, I.A. Basarau, M Manea, I.R. Papacocea, A.M. Ciobanu    Cinnarizine – Potential Trigger of the Dopamine Supersensitivity Psychosis in Patients with Paranoid Schizophrenia Particular neurobiochemical model   REV.CHIM.(Bucharest), 70, No. 8, 2019, p 3003-3007,  http://www.revistadechimie.ro. Impact factor 1,755.

6.Bondoc EN, Marinescu D, Marinescu I, et al. Current understanding of psycho-neurobiology in depressive disorders with suicidal thoughts – translational models. Romanian Journal of Morphology and Embryology, 2019 ;60(2):389-402. Impact factor 1,411.

7.Stovicek PO, Friedmann C, Marinescu D, et al. Mild TBI in the elderly – risk factor for rapid cognitive impairment in Alzheimer’s disease. Romanian Journal of Morphology and Embryology, 2020 ;61(1):61-72. doi: 10.47162/rjme.61.1.07. Impact factor 1,411.

8.Ileana Marinescu, Ramona Adriana Schenker, Puiu Olivian Stovicek, Dragos Marinescu, Constantin Florin Ciobanu, Serban Iancu Papacocea, Mihnea Costin Manea, Razvan Ioan Papacocea, Mirela Manea, Roxana Chirita, Adela Magdalena Ciobanu, Biochemical Factors Involved in the Unfavorable Evolution of Prostate Cancer, 2019, Revista de Chimie 70 (9), 3343-3347. Impact factor 1,755

  1. G. S. Drăgoi, P. R. Melinte, D. Marinescu, I. Dincă, M. M. Botoran Perenity of phenotype changes undergone by neuronal structures inside human superior cervical sympathetic ganglion. Implications in pathology, Rom J Leg Med, 22(1)69-80(2014) DOI:10.4323/rjlm.2014.69

 

  1. ABSTRACTS PUBLISHED IN INTERNATIONAL JOURNALS:
  2. Udriştoiu T, Marinescu D. Anxiety in Triggering an Act of Murder in Schizophrenics. International Congress on Schizophrenia and Affective Psychoses, pp.96.Geneva,1991;
  3. Udriştoiu T, Marinescu D. Prognosis and Social Rehabilitation with Schizophrenics Which Have Commited Murder. International Congress on Schizophrenia and Affective Psychoses, pp.92, Geneva, 1991;
  4. Marinescu D, Udriştoiu T, Bălan I, Mihăescu C. Suicide and Family. 4-th European Symposium on Suicidal Behaviour – Intervention and Prevention, pp.72, Odense, 1992;
  5. Bădescu G, Udriştoiu T, Marinescu D, Arsene S. Suicide in the City of Craiova. 4-th European Symposium on Suicidal Behaviour – Intervention and Prevention, pp.53, Odense, 1992;
  6. Udriştoiu T, Arsene S, Bădescu G, Marinescu D. Suicide – clinical and nosological aspects – 4-th European Symposium of Suicidal Behaviour – Intervention and Prevention, Odense, 10-13 June 1992, Denmark;
  7. Udriştoiu T, Marinescu D, Mihăescu C. Paricide and the psychiatric patients – First European Symposium on Aggresion in Clinical Practice, Stockholm, 9-10 Sept. 1992;
  8. Udriştoiu T, Marinescu D, Mihăescu C. The psychic disease and infanticid – First European Symposium on Aggresion in Clinical Practice, Stockholm, 9-10 Sept. 1992;
  9. Udriştoiu T, Marinescu D, Mihăescu C. Violence and vulnerability – First European Symposium on Aggresion in Clinical Practice, Stockholm, 9-10 Sept. 1992;
  10. Mihăescu C, Udriştoiu T, Marinescu D. Psychopharmacological aspects of treatmant with piracetam – 15-th Danube Symposium of Psychiatry, Regensburg, 7-10 October 1992, Germany;
  11. Udriştoiu T, Marinescu D. Suicide in major depression – Sixth European Symposium on Suicide and Suicidal Behaviour, University Hospital, Lund, Sweden, June 12-15, 1996;
  12. Marinescu D, Udriştoiu T. Biological therapiers in depression. International Symposium “Psychiatry and Human Condition”, pp.61, Iaşi, 1995;
  13. Udriştoiu T, Marinescu D, Mihăescu C – Sindromul psihoendocrin în clinica de psihiatrie. Acta Neurologica Moldavica, 4, 1-2, pp.88, 1996;
  14. Bădescu G, Udriştoiu T, Marinescu D. Aggressivenes and suicidal attempts in epilepsy. 7th European Symposium on suicide and suicidal behaviour “The suicidal process challenges for treatment and prevention”, 9-12 sept. 1998, Gent, Belgia;
  15. Udriştoiu T, Marinescu D, Bădescu G. Suicide in children and teenagers. 7th European Symposium on suicide and suicidal behaviour “The suicidal process challenges for treatment and prevention”, 9-12 sept. 1998, Gent, Belgia;
  16. Marinescu D, Udriştoiu T, Mihăescu C. Vulnerability and suicidal behaviour. 7th European Symposium on suicide and suicidal behaviour “The suicidal process challenges for treatment and prevention”, 9-12 sept. 1998, Gent, Belgia;
  17. Udriştoiu T, Marinescu D, Arsene S. Parasuicide in psychiatric hospital. 7th European Symposium on suicide and suicidal behaviour “The suicidal process challenges for treatment and prevention”, 9-12 sept. 1998, Gent, Belgia;
  18. Marinescu D, Udriştoiu T, Marinescu OR. Alprazolam (Xanax) – one alternative antidepressive drug – a psychopharmacological model. Rezumat în “Psihiatrie Danubiană”, vol. 10, nr. 3, Iulie – Sept. 1998, 347;
  19. Udriştoiu T, Marinescu D, Panait OD. New antidepressant psychopharmacological profile. in vol.: XVeme session des journes medicales Balkaniques – Iaşi, 28-30 Aprilie 1999;
  20. Udriştoiu T, Marinescu D. Atypical neuroleptics – psychopharmacology and attempted classification. 12 ECNP Congress, London, Sept. 21-25, 1999. Poster (P2. 206), 92;
  21. Marinescu D, Udriştoiu T, Chiriţă A. Biological and psychological vulnerability in depressive diseases in HIV(+) patients. The 2nd International Conference on the Synthesis between Psychopharmacotherapy and psychotherapy. Geneva, 20-23 Oct. 1999, 112;
  22. Marinescu D, Udriştoiu T, Chiriţă A. A neurobiological model of suicidal behaviour. XX Congress of the International Association of Suicid Prevention. Athens, 6-10 Nov. 1999, 236;
  23. Marinescu D, Udristoiu T, Mihaescu C, Chiriţă A. For an actual clinical and psychopharmacological classification of antidepressant substances. In vol.: XVeme session des journes medicales Balkaniques, Iasi, 28 – 30 Aprilie 1999;
  24. Udristoiu T, Marinescu D, Panait OD. New antidepressant psychopharmacological profile. In vol. : XVeme session des journes medicale Balkaniques – Iasi, 28 – 30 Aprilie 1999;
  25. Marinescu D, Udriştoiu T, Chiriţă A. Role of the Dopaminergic System and of the Cortico-Thalamic Circuits in the Cognitive Impairment in Schizophrenia. CINP Hungarian Regional Congress, Budapest, 2001;
  26. Udristoiu T, Marinescu D, Chiriţă A, Udriştoiu I. Biochemical and Immunitary Markers in Depression Word Psychiatric Association International Congress sept.-oct. 2001, Madrid FP 7.3, pp.40;
  27. Marinescu D, Udriştoiu T, Chiriţă A. Molecular Genetics of Schizophrenia, Psychopharmacological Approaches. 2nd ECNP Workshop, Nice, 2002;
  28. Marinescu D. Strategies with new antidepressants. European Neuropsychopharmacology, vol. 12, supp. 2, Aprilie 2002, S 33.
  29. Udriştoiu T, Marinescu D, Udriştoiu I, Chiriţă A. Implication and role of the thalamus in schizophrenia, 15 th, ECNP Congress, October, 2002, Barcelona, P.2.316.
  30. Udriştoiu T, Marinescu D, Udriştoiu I, Chiriţă A. Sexual disfunction in woman depression, 2nd Regional ISPNE Congress, Abstract Book, pag.68, June 6-8, 2002, Bucureşti.
  31. Marinescu D, Udriştoiu T, Udriştoiu I. Psychopathological aspects in hysterectomy, 2nd Regional ISPNE Congress, Abstract Book, pag.108, June 6-8, 2002, Bucureşti.
  32. Marinescu D, Udristoiu T, Chirita A. Present psychopharmacological prospects for the treatment of amphetamine abstinence sydrome in persons with suicidal risk, European Neuropsychopharmacology, vol. 13, suppl. 1, march 2003, The 4th ECNP Workshop 2003 Neuropsychopharmacology of addiction, Nice, France, March 15-17, 2003.
  33. Marinescu D, Mogoantă L, Udristoiu T. Hypercortisolemia-induced hippocampal effects and antidepressant drugs. Preliminary report, 16 th Congress of the European College of Neuropsychopharmacology, Prague, September, 20-24, 2003. Vol. 13, Supp.4, European Neuropsychopharmacology. S. 217.
  34. Marinescu D, Mogoantă L, Udriştoiu T. The anticholinergic effect of haloperidol vs. Sulpiride on rats, International Congress of Biological Psychiatry, Sydney, Australia, 9-13 February, 2004.pp.41
  35. Marinescu D, Udriştoiu T, Chiriţă AL. The amisulpride and trazodone association in depression with suicidal behaviour in patients with schizophrenia and sexual dysfunction, XXIV CINP Congress, Paris, June 20-24, 2004.
  36. Udriştoiu T, Marinescu D, Panait O, Ignat M. Suicidal behaviour in elderly people, 10 th European Symposium on Suicide and Suicidal Behaviour, Copenhagen, 25-28 august, 2004.
  37. Tudor C, Gheorghe MD, Grigorescu G, Marinescu D. Clinical assessment of NaSSA vs. SSRI efficacy in major depressive episode, The Journal of the European College of Neuropsychopharmacology, Volume, Supplement, 2004, 17th Congress of the European College of Neuropsychopharmacology, Octomber 9 – 13, 2004, Stockholm, Sweden.
  38. Udriştoiu T, Marinescu D, Udriştoiu I. The efficacy of olanzapine in the management of recurrent major depressive disorders, World Psychiatric Association,Regional & Intersectorial Congress Advances in psychiatry,Athens, Greece, March, 12-15, 2005.
  39. Marinescu I, Marinescu D, Chiriţă A. The improvment of facial immobility – Potential marker of outcome in he therapy of schizophrenia with negative symptoms in patient with recorded obstetrical traumas, The World Journal of Biological Psychiatry, Volume 6, Supplement 1, 2005, 8th World Congress of Biological Psychiatry, June 28th – July 3rd, 2005, Vienna, Austria.
  40. Marinescu D, Udriştoiu T, Chiriţă A. For a psychopharmacological model of the noncholinergic mechanism in degenerative dementias, World Psychiatric Association, Regional & Intersectorial Congress Advances in psychiatry,Athens, Greece, March, 12-15, 2005.
  41. Marinescu D, Udriştoiu T, Mogoantă L. Neurobiological Changes Induced by Cholinergic Blockade in The Cognitive Structures. A Comparative Study of Tricyclics vs. Trazodone on Animal Model, The World Journal of Biological Psychiatry, Volume 6, Supplement 1, 2005, 8th World Congress of Biological Psychiatry, June 28th – July 3rd, 2005, Vienna, Austria.
  42. Marinescu D, Udriştoiu T, Chiriţă A. Depressive prodromal syndrome in Alzheimer’s disease (ad) clinical and pharmacological correlations, 14 th European Congress of Psychiatry, Nice, France, March 4-8, 2006.
  43. Marinescu D, Mogoantă L, Udriştoiu T, Udriştoiu I. Neuroprotective effect of haloperidol, sulpiride, ziprasidone and olanzapine at hippocampal and frontal cortex at rats-20th ECNP Congress, Vienna, Austria.
  44. Marinescu D, Udristoiu T, Pirlog M, Udristoiu I, Chimorgiachis A. Weight gain in patients with schizophrenia and atypical antipsychotic treatment neurobiological correlations – Journal of Neural Transmission, vol. 114, no.7, 2007, 39th International Danube Symposium and 1st International Congress on ADHD, Wurzburg, 2-5 iunie 2007.
  45. Marinescu D, Udristoiu T, Camen D, Tiugan A, Chimorgiachis A, Radu C. Implication of the vascular factor in treatment resistance to patients with schizophrenia treated with antipsychotics, European Archives of Psychiatry + Cinical Neuroscience, vol. 257, Suppl. 1, September 2007, 1st European Conference on Schizophrenia Research , 26-28 September 2007, Dusseldorf, Germany
  46. Ciucu A, Negulescu C, Ciobanu A, Marinescu D, Negulescu A, Mihailciuc C. Voltammetric determination of neurotransmitters on metallophthalocyanine chemically modified carbon paste electrodes, Euroanalysis IX Congress, Antwerp, Belgia, 14 september 2007
  47. Marinescu I, Marinescu D. The evaluation of the efficacy of psychokinetotherapeutical technics in depressive vascular disorder associated with peripheral paresis of the facial nerve, International Journal of Psychiatry in Clinical Practice, Volume 11, Issue 4, 2007 , pages 295 – 340, Abstracts from the 7th international forum on mood and anxiety disorders, 5 – 7 December, 2007 Budapest, Hungary
  48. Marinescu D, Mogoanta L, Udristoiu T. The evaluation of the vascular risk factors for Alzheimer’s Disease in prodromal depresive syndrome associates with MCI, International Journal of Psychiatry in Clinical Practice, Volume 11, Issue 4, 2007 , pages 295 – 340, Abstracts from the 7th international forum on mood and anxiety disorders, 5 – 7 December, 2007 Budapest, Hungary
  49. Stovicek O, Marinescu D, Pîrlog M. Risk factors in Alzheimer’s Disease evolution for patients with MCI, European Pshychiatry, April 2008, Vol. 23, Suppl. 2, 16th AEP Congress, Nice, 5-9 April 2008.
  50. Chimorgiachis A, Marinescu D, Pîrlog M. Weight gain as a marker of evolution to patients with multiple episodes schizophrenia and atypical antipsychotic treatment, European Pshychiatry, April 2008, Vol. 23, Suppl. 2, 16th AEP Congress, Nice, 5-9 April 2008.
  51. Marinescu I, Marinescu D. The Evaluation of the Efficacy of Psychokinetotherapeutical Technics in Depressive Vascular Disorder Associated with Peripheral Paresis of the Facial Nerve, European Pshychiatry, April 2008, Vol. 23, Suppl. 2, 16th AEP Congress, Nice, 5-9 April 2008.
  52. Marinescu D, Mogoantă L, Udriştoiu T, Udriştoiu I. Neuroprotective Effect of Haloperidol, Sulpiride, Ziprasidone and Olanzapine at Hippocampal and Frontal Cortex at Rats, European Pshychiatry, April 2008, Vol. 23, Suppl. 2, 16th AEP Congress, Nice, 5-9 April 2008.
  53. Marinescu D, Udriştoiu T, Pîrlog MC, Marinescu I, Chimorgiachis A. Neurobiological and evolutive correlations at patients with schizophrenia and aggressive behaviour, The International Journal of Neuropsychopharmacology, Suppl. 1, Abstracts from the XXVI CINP Congress, Munich, 13-17 July 2008.
  54. Marinescu D, Mogoantă L, Udriştoiu T. The Evaluation of Neuroprotective Effect of Cerebrolysin in Alzheimer’s Disease on Animal Model, Česká a slovenská psychiatrie, Journal of Czech and Slovak Psychiatry XIV World Congress of Psychiatry, 20-25 September 2008, Prague, Czech Republic, Abstracts, Supplementum 2, Vol. 104 September 2008
  55. Udriştoiu T, Udriştoiu I, Marinescu D. Towards a Psychiatric Policy for East-EuropeanCountries and Balkans, Česká a slovenská psychiatrie, Journal of Czech and Slovak Psychiatry XIV World Congress of Psychiatry, 20-25 September 2008, Prague, Czech Republic, Abstracts, Supplementum 2, Vol. 104 September 2008
  56. Marinescu D, Marinescu I, Pîrlog M. The Role of biochemical and immunological markers in antidepressant treatment, International Journal of Psychiatry in Clinical Practice, vol 12, Number 4, november 2008, Abstracts from 8th International Forum on Mood and Anxiety Disorder, Vienna, 12-14 november, 2008.
  57. Marinescu D, Mogoantă L, Udriştoiu T. The comparred effect of Zyprasidone and Haloperidol at hippocampal and frontal cortex at rats, European Psychiatry – The Journal of European Psychiatric Association, Suppl. CD-ROM for 17th European Congress of Psychiatry, January 24-28, 2009, Lisbon Portugal
  58. Marinescu D, Mogoantă L, Udriştoiu T. The Evaluation of Neuroprotective Effect of Cerebrolysin in Alzheimer’s Disease with Psychotic Symptoms on Animal Model, Second Joint Congress of GCNN and SSNN, Vienna 1-3 March 2009.
  59. Marinescu D, Mogoantă L, Udriştoiu T, Udriştoiu I, Marinescu I, Pîrlog M. Neuroprotective effect of amitriptiline, haloperidol, sulpiride at hippocampal and frontal cortex at rats, CINP International Thematic Meeting, Edinburgh 25th – 27th April 2009.
  60. Marinescu D, Udriştoiu T, Mogoantă L, Udriştoiu I, Marinescu I. Comparation between neuroprotective effect of Haloperidol, Ziprasidone and Olanzapine in hippocampal and frontal cortex at rats, 10th International Congress of Clinical Pharmacology, Therapeutics and Toxicology, Sinaia 9-12 June 2009
  61. Marinescu D, Marinescu I, Bondari D, Pîrlog M, Chimorgiachis A, Bondari S. Neurobiological vulnerability determined by vascular factor in schizophrenia, The World Journal of Biological Psychiatry, vol. 10, suppl. 1, 2009, 9th World Congress of Biological Psychiatry, 28 june – 2 july 2009, Paris, France.
  62. Mogoantă L, Marinescu D, Udriştoiu T. Neuroprotection and cardioprotection for the antipsychotics with long-term action (animal model study), The World Journal of Biological Psychiatry, vol. 10, suppl. 1, 2009, 9th World Congress of Biological Psychiatry, 28 june – 2 july 2009, Paris, France.
  63. Pîrlog M, Marinescu D, Marinescu I. The role of stress factors in the weight gain of the patients with schizophrenia and antipsychotic treatment, European Archives of Psychiatry and Clinical Neuroscience, Volume 259, Issue 1 Supplement, September 2009, 2nd European Conference on Schizophrenia Research: From Research to Practice ISSN: 0940-1334 (Print) 1433-8491.
  64. Marinescu D, Mogoanta L, Udristoiu T. Neuroprotective effect of Haloperidol vs. Aripiprazole at hippocampal and frontal cortex at rats, European Psychiatry – The Journal of European Psychiatric Association, Vol. 25, Suppl.1, 2010, (P03-353), 18th European Congress of Psychiatry, February 27 – March 2, 2010, Munchen, Germany
  65. Marinescu D, Marinescu I, Pirlog M, Chimorgiachis A. Aripiprazole in prodromal syndrome of schizophrenia at the male patients with obstetrical traumas in personal medical history, European Psychiatry – The Journal of European Psychiatric Association, Vol. 25, Suppl.1, 2010, (P03-352), 18th European Congress of Psychiatry, February 27 – March 2, 2010, Munchen, Germany
  66. Pîrlog M, Marinescu D, Marinescu I. The Social Cognition in the Treatment of Schizophrenia with Long Action Antipsychotics, European Psychiatry – The Journal of European Psychiatric Association, Vol. 25, Suppl.1, 2010, (P03-180), 18th European Congress of Psychiatry, February 27 – March 2, 2010, Munchen, Germany
  67. Marinescu D, Marinescu I, Pîrlog M, Chimorgiacis A. Corelaţii neurobiologice şi psihofarmacologice în depresia prin deficit de dopamină, A IV-a Conferinţă Internaţională de Psihiatrie Româno-Maghiară, Miercurea Ciuc, 24-26 iunie 2010
  68. Marinescu D, Mogoantă L, Udriştoiu T. Discontinuity of treatment with antipsychotics and neurostructural changes on animal model, 23rd ECNP Congress, 28 August – 1 September 2010, Amsterdam, The Netherlands.
  69. Mogoantă L, Marinescu D, Udriştoiu T, Udriştoiu I, Pirici D. Neuroprotective effect of cerebrolysin and erythropoietin vs. haloperidol in Alzheimer’s Disease – animal model, 23rd ECNP Congress, 28 August – 1 September 2010, Amsterdam, The Netherlands.
  70. Marinescu I, Marinescu D, Pîrlog M, Chimorgiachis A. Weight gain as a marker of evolution to patients with multiple episodes schizophrenia and depressive symptoms, 23rd ECNP Congress, 28 August – 1 September 2010, Amsterdam, The Netherlands
  71. Marinescu I, Marinescu D, Pirlog MC. Neurobiological and somatic particularities at women with depressive disorder, European Psychiatry – The Journal of European Psychiatric Association, Abstracts Vol. 26, Suppl.1, 2011, (P02-54), 19th European Congress of Psychiatry, 12-15 March 2011, Vienna, Austria.
  72. Marinescu D, Mogoanta L, Udristoiu T, Udristoiu I, Pirici D. The neuroprotective potentially of agomelatine – animal model study, European Psychiatry – The Journal of European Psychiatric Association, Abstracts Vol. 26, Suppl.1, 2011, (P03-87), 19th European Congress of Psychiatry, 12-15 March 2011, Vienna, Austria.
  73. Pirlog MC, Marinescu D, Marinescu I. Psychosocial particularities for adherence concept at chronic schizophrenia patients, European Psychiatry – The Journal of European Psychiatric Association, Abstracts Vol. 26, Suppl.1, 2011, (P03-307), 19th European Congress of Psychiatry, 12-15 March 2011, Vienna, Austria.
  74. Marinescu D, Udristoiu T, Mogoanta L. Neuroprotection and cardioprotection of flupentixol decanoate vs. olanzapine long-acting injection (animal model study), Abstract cd-rom, 10th World Congress of Biological Psychiatry, 29 May – 2 June 2011, Prague, Czech Republic DOI: 10.3284/wfsbp.2011.1
  75. Marinescu I, Marinescu D, Pirlog M. The relationship between weight gain at depressive women and neurobiological risks, Abstract cd-rom, 10th World Congress of Biological Psychiatry, 29 May – 2 June 2011, Prague, Czech Republic DOI: 10.3284/wfsbp.2011.1
  76. Marinescu D, Marinescu I, Pirlog MC. Metabolic syndrome in women with depressive disorder versus schizophrenia, European Neuropsychopharmacology, The Journal of the European College of Neuropsychopharmacology, VOLUME 21 (2011) Supplement 3, Papers of the 24th ECNP Congress 3-7 September 2011 Paris, France
  77. Marinescu D, Udristoiu T, Mogoanta L, Udristoiu I, Pirici D. Neuroprotective potential of agomelatine for depression in Alzheimer’s disease: animal model study, European Neuropsychopharmacology, The Journal of the European College of Neuropsychopharmacology, VOLUME 21 (2011) Supplement 3, Papers of the 24th ECNP Congress 3-7 September 2011 Paris, France.
  78. Marinescu D, Mogoanta L, Udristoiu I, Marinescu I, Pirlog MC, Pirici D. Comparative study on animal model of neuroprotection and cardioprotection for long acting antipsychotics, European Archives of Psychiatry + Clinical Neurosciences, Volume 261, Supplement 1, September 2011, 3rd European Conference on Schizophrenia Research: Fact and Visions, 29 september – 1 octomber 2011, Berlin, Germany.
  79. Marinescu D, Mogoantă L, Udriştoiu T, Marinescu I, Udriştoiu I, Pirici D – The neuroprotective role of rivastigmine in the treatment with haloperidol (animal model), The international Journal of Neuopsychopharmacology, Volume 15, Supplement 1, June 2012, Abstracts from the 28th CINP World Congress of Neuropsychopharmacology, Stockholm, Sweden, 3-7 June 2012.
  80. Marinescu D, Udriştoiu T, Marinescu I, Udriştoiu I. Particularities of neurobiological models in early psychosis, Psychiatria Danubina, 2012, The 25th Danube Symposium of Psychiatry, Psychiatry, Medicine and Society, Timişoara, Romania, September 26-29, 2012.
  81. Pîrlog M, Marinescu D. Neurobiological background of social cognition in schizophrenia, Psychiatria Danubina, 2012, The 25th Danube Symposium of Psychiatry, Psychiatry, Medicine and Society, Timişoara, Romania, September 26-29, 2012.
  82. Marinescu D, Udriştoiu T, Mogoantă L, Marinescu I, Udriştoiu I. The Neuroprotective Role of Rivastigmine vs. Agomelatine in Treatment with Haloperidole (Animal Model), WPA 2013 Bucharest Congress, 10-13 April, 2013.
  83. Pirlog MC, Marinescu IP, Ristea S, Marinescu D. The role of psychosocial factors in schizophrenia with unfavorable evolution, 21st World Congress Social Psychiatry, 29 June – 3 July 2013, Lisbon, Portugal
  84. Udristoiu T, Pirlog MC, Mogoanta L, Marinescu D, Marinescu I, Udristoiu I, Pirici D. Frontal cortex neuroprotection – significant target for improving social cognition in patients with schizophrenia treated with long-action antipsychotics, 11th World Congress of Biological Psychiatry, 23-27 June 2013, Kyoto, Japan.
  85. Pirlog MC, Marinescu I, Marinescu D. Comparative assessment of the social performances for schizophrenic patients treated with long acting antipsychotics, European Archives of Psychiatry + Clinical Neurosciences, Volume 263, Supplement 1, September 2013, 4th European Conference on Schizophrenia Research: Together for Better Treatment and Care, 26 – 28 september 2013, Berlin, Germany.
  86. Marinescu D, Mogoanta L, Udristoiu T, Udristoiu I, Marinescu I. Assessment of neuroprotective effects in the basal ganglia and cerebellum for haloperidol (animal model), World Psychiatric Association International Congress 2013, October 27–30, 2013, Vienna, Austria
  87. Marinescu I, Pirlog MC, Marinescu D. Cerebral structural changes in depression in women – markers for low quality of life, World Psychiatric Association International Congress 2013, October 27–30, 2013, Vienna, Austria
  88. Pirlog MC, Marinescu I, Marinescu D. Aggressive behavior and social stress in schizophrenic outpatients, XVI World Congress of the World Psychiatric Association, September 14–18, 2013, Madrid, Spain
  89. Udristoiu T, Militaru F, Marinescu I, Udristoiu I. Psychiatry: Somewhere or nowhere?, XVI World Congress of the World Psychiatric Association, September 14–18, 2013, Madrid, Spain
  90. Udristoiu T, Mogoanta L, Marinescu I, Udristoiu I, Marinescu D. The neuroprotective effect in frontal cortex – a comparative study of haloperidol, ziprasidone and olanzapine, XVI World Congress of the World Psychiatric Association, September 14–18, 2013, Madrid, Spain
  91. Dinca EB, Marinescu D. Use of Clozapine in Treatment-Resistant Schizophrenia in Community Mental Health Teams (CMHT) in England, XVI World Congress of the World Psychiatric Association, September 14–18, 2013, Madrid, Spain
  92. Udristoiu T, Mogoanta L, Udristoiu I, Marinescu I, Marinescu D. Paliperidone palmitate versus haloperidol decanoate – an animal study, 27th ECNP Congress, 18-21 October 2014, Berlin Germany, Eur Neuropsychopharmacol. 2014;24(Suppl 2):S238
  93. PirlogM, Marinescu I, Marinescu D. Correlation of quality of life with cerebral abnormalities in patients with schizophrenia treated with long-acting antipsychotics, 27th ECNP Congress, 18-21 October 2014, Berlin Germany, Eur Neuropsychopharmacol. 2014;24(Suppl 2):S510
  94. Marinescu D, Mogoanta M, Marinescu I, Pirlog M. Neuroprotection of Frontal Cortex and Hippocampus for Antipsychotics used in Treatment of Depressive Disorder (animal model), 14th International Forum on Mood and Anxiety Dsorders, Viena, 10-12 December 2014 (http://www.ifmad.org/2014/).
  95. Mogoanta L, Marinescu D, Marinescu I, Pirlog M. Antipsychotic induced catalepsy – Possible neurodegenerative marker in schizophrenia (Animal model study), Neurodegener Dis 2015;15:(suppl 1):I-II (DOI:10.1159/000381110), Mechanisms, Clinical Strategies, and Promising Treatments of Neurodegenerative Diseases. 12th International Conference AD/PDTM Nice, France, March 18-22, 2015: Abstracts
  96. Pirlog M, Marinescu I, Marinescu D. Antisocial Behavior and Psychomotor Agitation. Emphasizing Factor of the Burden of Disease in Schizophrenia, European Psychiatry, Volume 30, Supplement 1, (2015), Abstracts of the 23rd European Congress of Psychiatry (EPA 2015), Vienna, 28-31 March 2015.
  97. T. Udristoiu, L. Mogoanta, I. Marinescu, D. Marinescu, F. Militaru. Different neuroprotection between olanzapine and aripiprazole in rats, 12th World Congress of Biological Psychiatry, 14-18 June 2015, Athens, Greece
  98. D. Marinescu, L. Mogoanta, T. Udristoiu, I. Marinescu. The neuroprotective role of rivastigmine during the treatment with amitriptyline on animal model, 12th World Congress of Biological Psychiatry, 14-18 June 2015, Athens, Greece
  99. Mutica M, Marinescu I, Marinescu D, Pirlog MC. Cognitive Deficit Deficit in Female Patients with Chronic Schizophrenia, 5th European Conference on Schizophrenia Research ECSR 2015, 24-26 September 2015, European Archives of Psychiatry + Clinical Neuroscience, Vol 265, Suppl 1, September 2015.

 

  1. ARTICLES PUBLISHED IN NATIONAL JOURNALS
  2. Olaru Al, Cernătescu M, Marinescu D. Improved outpatient assistance by association of depot psychotropes in the treatment of psychotics pursued by L.S.M. Craiova, Annals of the University of Craiova, Medical Sciences Series, 1980, pp.101-105
  3. Olaru Al, Marinescu D, Arsene S. From psycho-neurologic microsimptoma to major deterioration in cerebral atherosclerosis, Annals of the University of Craiova, Medical Sciences Series, vol. IX, 1984, pp. 68-71.
  4. Roşca Tr, Olaru Al, Bistriceanu M, Mocanu I, Marinescu D. Endocrinoreactivity study in manic-depressive syndrome and schizophrenia, Annals of the University of Craiova, Medical Sciences Series, vol. X, 1985, pp. 41-43.
  5. Olaru Al, Marinescu D, Arsene S. Clinical and Statistical Aspects of Mixed Alcohol and Saturation Poisoning, Annals of the University of Craiova, Medical Sciences Series, vol. X, 1985, pp. 75-61.
  6. Olaru Al, Arsene S, Bădescu G, Marinescu D, Balan I. Psychiatry in the opinion of the students and graduates of the Faculty of Medicine, Craiova, Annals of the University of Craiova, Medical Sciences Series, vol. XI, 1986, pp. 60-66.
  7. Olaru Al, Marinescu D, Arsene S. Catamneza of postpartum psychosis cases admitted in the Clinic of Psychiatry Craiova between 1971-1980, Annals of the University of Craiova, Medical Sciences Series, Vol. XII-XIII, 1987, pp. 54-58.
  8. Udriştoiu T, Marinescu D. Aspects of psychiatric morbidity in a chemical combination, Annals of the University of Craiova, XII-XIII, pp. 54-58, 1987;
  9. Udriştoiu T, Marinescu D. Anxiety and Crime – Annals of the University of Craiova, XIV, pp.70-72, 1988;
  10. Marinescu D, Udriştoiu T, Marinescu R. Alcoolisme: actualites cliniques et psychopathologiques – Annals of the University of Craiova, XIV, pp.61-64, 1988;
  11. Marinescu D, Udriştoiu T, Marinescu R. Early onset depressive disorders in the psychiatric clinic Craiova, Annals of the University of Craiova, XV, pp. 54-57, 1989;
  12. Udriştoiu T, Marinescu D. Alcoholism, pathophysiological and pathogenic currents – Annals of the University of Craiova, XV. pp. 67-70, 1989;
  13. Marinescu D, Udriştoiu T. Psychiatric Aspects of the Adaptation of a Group of New Workers – Annals of the University of Craiova, XVI, pp. 76-79, 1989;
  14. Marinescu D, Udriştoiu T. Murder murder in psychiatric patients – Annals of the University of Craiova, XVII, pp.75-78, 1991;
  15. Udriştoiu T, Marinescu D. The first regulation of organization and functioning of a psychiatric unit in Oltenia – Annals of the University of Craiova, XVII, pp.87-89, 1991;
  16. Udriştoiu T, Marinescu D, Arsene S, Mihăescu C. Depression and cognitive deficit in the advanced age – Psychiatry, Pedopsychiatry, Medical Psychology – new series, 2-3, pp. 25-28, 1993;
  17. Udriştoiu T, Marinescu D. Significant and random in the dispensarization-rehabilitation relation of psychiatric patients – Psychiatry in Society (under T.Pirozinski’s ed.), Ed.Psih.Omnia, pp.121-127, Iaşi, 1994;
  18. Marinescu D, Udriştoiu T. Biochemical Vulnerability – Psychopathological and Therapeutical Implications – Psychiatry in the Society (under T.Pirozinski), Ed.Psih.Omnia, pp.143-148, Iaşi, 1994;
  19. Udriştoiu T, Marinescu D. Marginal psychiatric disorders at the students admitted to the psychiatric clinic, Annals of the University of Craiova, XVII, pp.112-116, 1994;
  20. Udriştoiu T, Marinescu D. Evolutionary-prognostic aspects of the paroxysmal anxiety crises in children and adolescents, Annals of the University of Craiova, XVII, pp.117-119, 1994;
  21. Marinescu D, Udriştoiu T. Biochemical, EEG and Immunological Indicators for Primary Depressive Syndromes, Annals of the University of Craiova, XVII, pp. 120-124, 1994;
  22. Udriştoiu T, Marinescu D, Mihăescu C. Psychological Illness and Offense – Annals of the University of Oradea, 1, pp. 42-46, 1995;
  23. Marinescu D, Marinescu R, Udriştoiu T. The Fantastic and Anticipation in the Psychopathological Perspective – Transcultural Anthropology Essay – Annals of the University of Oradea, 1, pp. 47-49, 1995;
  24. Marinescu D, Udriştoiu T, Mihăescu C. The attempted murder murder in psychiatric patients – Annals of the University of Oradea, 1, pp.156-159, 1995;
  25. Marinescu D, Udriştoiu T, Bădescu G, Arsene S. Is fluanxol an antidepressant? – Annals of the University of Oradea, 1, pp.159-162, 1995;
  26. Marinescu D, Udriştoiu T. Biological therapies in resistant depressions. Psychiatry and Human Condition, pp. 259-261 – Ed.Psih.Omnia, Iaşi, 1995;
  27. Udriştoiu T, Marinescu D, Marinescu R. Family Alcoholism in Child and Adolescent Pathology. Psychiatry and Human Condition, pp. 265-268 – Ed.Psih.Omnia, Iaşi, 1995;
  28. Udriştoiu T, Marinescu D, Arsene S, Bădescu G, Mihăescu C. Rehabilitation project for psychiatric care in the county of Dolj – Romanian Journal of Psychiatry, Pedopsychiatry and Medical Psychology, III, 2-3, pp.126-129, 1995 ;
  29. Udriştoiu T, Marinescu D, Mihăescu C, Larentzakis S. Aggressiveness, Antisocial Behavior, Mental Illness – General Theoretical Considerations – Annals of the University of Oradea, pp.60-64, 1996;
  30. Udriştoiu T, Marinescu D, Mihăescu C. Methodological difficulties of psycho-legal forensic expertise, Annals of the University of Oradea, pp.116-119, 1996;
  31. Udriştoiu T, Marinescu D. For a supple and dynamic application of safety measures – Annals of the University of Oradea, pp.221-224, 1996;
  32. Udriştoiu T, Marinescu D, Mihăescu C. Delinquency in Affective Pathology – Annals of the University of Oradea, pp. 297-300, 1996;
  33. Udriştoiu T, Marinescu D, Mihăescu C, Gruieţ L. Sexual Delinquency and Psychopathology – Annals of the University of Oradea, pp. 369-372, 1996;
  34. Udriştoiu T, Marinescu D, Mihăescu C. On the reconsideration of the Decree 313/1985 – Annals of the University of Oradea, pp. 387-390, 1996;
  35. Udriştoiu T, Marinescu D, Marinescu R. Family Alcoholism in Child and Adolescent Pathology, Annals of the University of Craiova, Medicine Series, Vol. No.1, pp.150-153, 1996;
  36. Udriştoiu T, Marinescu D. Psychoendocrine Syndrome in the Psychiatric Clinic – Integrative Psychiatry Bulletin, Vol. III, No. 1 (4), pp. 53-56, 1997;
  37. Udriştoiu T, Marinescu D, Kaplanoglu T. Evolutionary Aspects of Affective Disease. Bulletin of Integrative Psychiatry, Vol. III, No.1 (4). pp.108-111,1997;
  38. Udriştoiu T, Marinescu D. Suicidal Trial – A Neglected Reality – Integrative Psychiatry Bulletin, Vol. III, No.1 (4). pp.242-245,1997;
  39. Udriştoiu T, Marinescu D, Arsene S, Bădescu G, Mihăescu C. The dispensary assistance between desideratum and reality, Annals of the University of Oradea, Medicine Series no. 1, pp. 19-21;
  40. Marinescu D, Cârlig V, Udriştoiu T, Mihăescu C. Neuroleptics in the present psychopharmacological perspective, An. Univ. from Craiova, Medicine, vol. IV, no. 1, 1997, 117-120;
  41. Marinescu D, Udriştoiu T, Marinescu R. Schizophrenia of the child and adolescent in the perspective of biological psychological and psychopharmacological clinical, An. Univ. from Craiova, Medicine, vol. IV, no. 2, 1997, 245-249;
  42. Udriştoiu T, Marinescu D. Medical Psychology in the Perspective of Vulnerability. In the volume “35 Years of Psychiatric Assistance in Botosani”, vol. I, 25-27 Sept. 1997, 35-38;
  43. Marinescu D, Udriştoiu T, Mihăescu C. Neurobiological changes in schizophrenia and affective illness. In the volume “35 Years of Psychiatric Assistance in Botosani”, vol. I, 25-27 Sept. 1997, 276-280;
  44. Hook V, Marinescu D, Bădulescu F. Effects of the association of midazolam-flumazinil on smooth intestinal muscles, Year. Univ. of Craiova, Medicine, vol. IV, no. 2, 1997, 284-288.
  45. Udriştoiu T, Marinescu D, Mihăescu C. About anxiety. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 3-8;
  46. Marinescu D, Udriştoiu T, Mihăescu C. The GABA-ergic mechanisms involved in major psychiatric sufferings. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 9-12;
  47. ​​Marinescu D, Udriştoiu T, Mihăescu C. Benzodiazepines. Xanax (Alprazolam). Psychopharmacological perspectives. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 16-23;
  48. Udriştoiu T, Marinescu D, Boiangiu C. Xanax (Alprazolam) as non-conventional antidepressant. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 24-27;
  49. Marinescu D, Marinescu R. Xanax (Alprazolam) in the pedopsychiatry therapy of anxiety and obsessive-compulsive disorders. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 28-34
  50. Udriştoiu T, Marinescu D. Xanax (Alprazolam) in anxiety disorders. In the volume “XANAX – the art of effectively treating anxiety at all ages”, Pharmacia Upjohn, Craiova, 1997, 35-37;
  51. Marinescu D, Udriştoiu T, Boiangiu C. Cerebral and non-responsiveness in schizophrenia. National Conference of Psychiatry “Psychopharmacological Therapy in Psychiatric Practice”, Rev. Romanian Neurology, Neurosurgery and Psychiatry, 2/3/1997, 24-25 Oct. Bucharest, 25-26;
  52. Udriştoiu T, Marinescu D, Mihăescu C, Panait OD. Atypical neuroleptics and cerebral neurotransmission. National Conference of Psychiatry “Psychopharmacological Therapy in Psychiatric Practice”, Rev. Romanian Neurology, Neurosurgery and Psychiatry, 2/3/1997, 24-25 Oct. Bucharest, 8;
  53. Udriştoiu T, Marinescu D, Mihăescu C. The occurrence of the phenomenon of long-term PTL potentiation of postsynaptic receptors in schizophrenia. National Conference of Psychiatry “Psychopharmacological Therapy in Psychiatric Practice”, Rev. Romanian Neurology, Neurosurgery and Psychiatry, 2/3/1997, 24-25 Oct. Bucharest, 6-7;
  54. Udriştoiu T, Marinescu D, Chiriţă A, Panait OD – Psychopharmacology of depressive syndromes versus therapeutic resistance. In the volume “Clinical Psychopharmacology”, under red. T. Pirozynski, Iaşi, 1998, 34-41;
  55. Udriştoiu T, Marinescu D, Chiriţă A, Mihăescu C – The atypical neuroleptics in the present psychopharmacological perspective. In the volume “Clinical Psychopharmacology”, under red. T. Pirozynski, Iaşi, 1998, 52-56;
  56. Marinescu D, Udriştoiu T, Boiangiu C – In the volume “Deviant Behavior in Socio-Family Relations”, under red. V. Chiriţă, Iaşi, 1998, 122-130;
  57. Marinescu D, Udriştoiu T, Marinescu Ruxandra, Marinescu, Oana Raluca – Psychopathological disorders in HIV infection. In the book “Perspectives in Psychiatric Assistance” under red. P. Boisteanu, Iasi, 1998, 144-149;
  58. Marinescu, D., Udriştoiu, T., Chiriţă, Anca, Panait, Oana Dana – Clinical-biological and psychopharmacological indicators for the therapeutic adequacy of depression. In the volume “Modern psychiatric taxonomy and specific psychopharmacology”, the National Conference on Psychiatry, Sept.-Oct. 1998, Bucharest, under red. G. Ionescu, 291-294;
  59. Udriştoiu, T., Marinescu, D. – Biological criteria for the use of atypical neuroleptics in the first episode of schizophrenia. In the volume “Modern psychiatric taxonomy and specific psychopharmacology”, the National Conference on Psychiatry, Sept.-Oct. 1998, Bucharest, under red. G. Ionescu, 355-356;
  60. Marinescu, D., Udriştoiu, T., Mihăescu, C., Marinescu, Oana Raluca – Clinical Parasitology and Psychopathology. In the Romanian Journal of Parasitology, vol. VIII, no. 2, 1998, 4-6;
  61. Udriştoiu, T., Marinescu, D., Panait, Oana Dana, Grigorescu, Lucica – Depression – Anxiety – Xanax. Abstract, in the volume “Days of Scientific Communications”, 27-29 May 1998, Constanta, 71;
  62. Marinescu, D., Udriştoiu, T., Cârlig, V., Mihăescu, C. – The drug therapy of post-traumatic stress disorder (PTSD). In “Therapeutic and Clinical Toxicology”, vol. II, no. 3, sept. 1998, Bucharest, 117-121;
  63. Marinescu, D., Udriştoiu, T., Hârlig, V., Georgescu, Simona – Arguments for a Possible Neurobiological Model of Suicidal Behavior. In Annals of the University of Craiova, Medicine series, vol. 5, no. 1, 1998, 7-11;
  64. Marinescu, D., Udriştoiu, T., Hârlig, V., Mihăescu, C. – Drug therapy of post-traumatic stress disorder (PTSD). Craiova Medical, vol. I, 1, 1999, 34-38;
  65. Marinescu, D., Udriştoiu, T., Chiriţă, Anca, Udriştoiu, I. – Vulnerability theory and personality disorders. Rev. Medical Orădeană, vol. 6, no. 1, 1999, 88-90;
  66. Udriştoiu, T., Marinescu, D., Udriştoiu, I., Marinescu, Oana Raluca – Psychopharmacological and Nosological Perspectives in the Biological Therapy of Personality Disorders. Rev. Medical Orădeană, vol. 6, no. 1, 1999, 277-282;
  67. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Neurobiological changes in schizophrenia. For an integrative type etiopathogenic model. Rev. Romanian Psychiatry, Series III, vol. 1, no. 1, 1999, 30-37;
  68. Udriştoiu, T., Marinescu, D., Panait, Oana, Grigoraşcu, L. – Xanax in the treatment of major psychiatric disorders. Current orientations in psychopharmacology. Anxiolytic medication between tradition and future, Pharmacia Upjohn, Constanta, pp. 244-26, 1998;
  69. Marinescu, D., Udriştoiu, T., Hârlig, V., Grigoraşcu, L. – Xanax in the therapy of anxiety disorders in old age. Current orientations in psychopharmacology. Anxiolytic medication between tradition and future, Pharmacia Upjohn, Constanta, pp. 27-30, 1998;
  70. Udriştoiu, T., Marinescu, D., Chiriţă, Anca, Mihăescu, C. – Epidemiological and Clinical Arguments for an Effective Therapeutic Approach to Anxiety Disorder. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders, pp.5-8, Pharmacia Upjohn, Craiova, 1998;
  71. Marinescu, D., Udriştoiu, T., Chiriţă, Anca, Galiceanu, Georgeta – For a neurobiochemical model of anxiety and obsessive-compulsive disorders. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders, pp. 8-13, 1998;
  72. Cârlig, V., Udriştoiu, T., Marinescu, D., Marinescu, O.R. – Use of benzodiazepines in somatic pathology. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders, pp.13-15, 1998;
  73. Udriştoiu, T., Marinescu, D., Mihăescu, C., Panait, O. – The role of Xanax in the treatment of schizophrenia and major depression. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders, pp. 244-27, 1998;
  74. Marinescu, D., Udriştoiu, T., Panait, O., Marinescu, O.R. – Xanax and psychopharmacology of alcoholism. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders. pp. 27-32, 1998;
  75. Udriştoiu, T., Marinescu, D., Hârlig, V., Panait, O. – Sleep disorders – taxonomic and psychopharmacological aspects. Current orientations in psychopharmacology, Modern therapeutic perspectives in anxiety disorders, pp. 32-42, 1998;
  76. Cârlig, V., Georgescu, C.C., Tica, A.A., Marinescu, D. – Aspects of interaction of Midazolam-Calciu in striatal musculature. In Annals of the University of Craiova, Medicine series, Vol. V, no. 1, 1998, pp. 158-160.
  77. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Neurobiological changes in schizophrenia – for an integrative-type pathogenic model. Romanian Journal of Psychiatry, Vol.1.Nr.1. pp.30-34. 1999;
  78. Marinescu, D., Udriştoiu, T., Cârlig, V., Mihăescu, C. – Drug therapy of post-traumatic stress disorder (PTSD), Craiova Medicală, vol. I, 1, 1999, pp.34- 38.
  79. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Re-evaluation of serotonin mechanisms in the pathogenesis and treatment of schizophrenia. Romanian Journal of Psychiatry, Vol. II, Nr. 1.pp.9-12. 2000;
  80. Marinescu, D., Udriştoiu, T., Chiriţă, Anca, Udriştoiu, I. – Vulnerability theory and personality disorders, Rev. Medical Orădeană, vol. 6, no. 1, 1999, pp. 88-90.
  81. Udriştoiu, T., Marinescu, D., Udriştoiu, I., Marinescu, Oana Raluca – Psychopharmacological and Nosological Perspectives in the Biological Therapy of Personality Disorders, Rev. Medical Orădeană, vol. 6, no. 1, 1999, pp. 277-282.
  82. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Neurobiological changes in schizophrenia. For an integrative type etiopathogenic model. Rev. Romanian Psychiatry, Series III, vol. 1, no. 1, 1999, pp. 30-37.
  83. Marinescu, D., Marinescu, Ruxandra, Gorner, I. – Evidence of Possible Predictors for Schizophrenia in Latency, in the Perspective of Biological Psychiatry – Report Rev. The XXth National Conference of Child and Adolescent Neurology and Psychiatry, Craiova, September 23-25, 1999, pp. 21-23.
  84. Marinescu, Ruxandra, Marinescu, D., Chiriţă, Anca – Depressive disorders in the child during the latency – Report Rev. The XXth National Conference of Child and Adolescent Neurology and Psychiatry, Craiova, September 23-25, 1999, pp. 21-23.
  85. Marinescu, D. – Treatment of depression: a problem that persists. In: Current orientations in psychopharmacology focus depression. Pharmacia & amp; Upjohn, 1999, 8.
  86. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Re-evaluation of serotonin mechanisms in the pathogenesis and treatment of schizophrenia. Rev. Romanian Psychiatry, no. 1, vol. II, 2000, pp.9-13.
  87. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Immune hypothesis and neuroopathological etiopatogenic model of schizophrenia. Romanian Journal of Psychiatry, Vol. II, No.2-3, pp. 84-88, 2000;
  88. Chiriţă, Anca, Bogdan, Fl., Udriştoiu, T., Marinescu, D. – Experimental effect of neuroleptics from the class of butirofen on laboratory animals. Romanian Journal of Psychiatry, Vol. II, No.2-3, pp.116-119, 2000;
  89. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – The role of the serotonin system in the etiopathogenesis and the therapy of schizophrenia. Craiova Medical, Vol.2.Nr.1.pp.9-12. 2000;
  90. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – The role of the GABA-ergic system in anxiety disorders and alcohol dependence. Craiova Medicală, Vol.2.Nr.2. pp.141-144, 2000;
  91. Udriştoiu, T., Marinescu, D., Marinescu, Oana Raluca, Chiriţă, Anca – Implications of the immune systems in the psychiatric clinic. Craiova Medicală, Vol.2.nr.3.pp.159-163, 2000;
  92. Udriştoiu, T. Marinescu, D., Chiriţă, Anca et al. – Serotonin in the pathophysiology and treatment of schizophrenia. Romanian Journal of Psychopharmacology, vol. I, no. 1, pp. 30-34, 2001;
  93. Marinescu, D., Udriştoiu, T., Marinescu, Oana Raluca. et al – Dopamine and genetics, cognitive deficits and treatment in schizophrenia. Romanian Journal of Psychopharmacology, vol. I, no. 1, pp. 81-85, 2001;
  94. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Biochemical and Neurobiological Perspectives in Anxiety Disorders – Romanian Journal of Psychopharmacology, Vol. II, no. 1.2 2002, pp. 44-50;
  95. Udriştoiu, T., Marinescu, D., Udriştoiu I., – Cognitive deficit in schizophrenia – Romanian Journal of Psychopharmacology, Vol. II, no. 1.2 2002, pp. 51-57.
  96. Bădescu, G., Marinescu, D. – Implications of temporal lobe structures in aggressive behavior, Craiova Medicală, Vol.4, nr.3, 2002, pp. 207-210.
  97. Marinescu, D., Udriştoiu, T., Chiriţă, Anca – Current Directorates of Neurobiological and Psychopharmacological Research in Schizophrenia, Craiova Medicală, Vol.4, nr.4, 2002, pp. 295-298.
  98. Udriştoiu, T., Marinescu, D., Bădescu, G., Miloşescu, A. – Aggressiveness. For a neurobiological model, Romanian Journal of Psychopharmacology, Vol. 3, No.3-4, 2003, pp. 112-118.
  99. Marinescu, D., Udriştoiu, T., Milosescu, A., Udriştoiu, I. – Clinical-evolutionary considerations on the prodrome of schizophrenia, Romanian Journal of Psychopharmacology, Vl.4, no.3-4,2004, pp.160 -166.
  100. Tsoli, Maria, Marinescu, D., Chiriţă, Anca – Considerations on early onset schizophrenia, Craiova Medical, vol. 6, No. 2, 2004, pp. 141-143.
  101. Marinescu, D., Udriştoiu, T., Udriştoiu, I. – For a classification of atypical antipsychotics, Romanian Journal of Psychopharmacology, Vol. 5, no.1-2,2005, pp. 28-33.
  102. Marinescu, D., Udriştoiu, T., Udriştoiu, I., Chiriţă, Anca – The therapeutic protocol in schizophrenia, Romanian Journal of Psychopharmacology, Vol. 5, no. 3-4, 2005, pp. 107-117.
  103. Udriştoiu, T., Marinescu, D., Udriştoiu, I., Popa, Luiza – Therapeutic Protocol in Major Depressive Disorder, Romanian Journal of Psychopharmacology, Vol.5, no.3-4,2005, pp. 118-127.
  104. Marinescu D, Mixich V, Chiriţă A. Gena DRD2 in schizophrenia and the action of antipsychotics Romanian Journal of Psychopharmacology, Vol. 5, no.3-4,2005, pp. 148-158.
  105. Udriştoiu, T., Marinescu, D., Udriştoiu, I., Popa, Luiza – Vulnerability and therapeutic resistance in depressive disorders. Romanian Journal of Psychopharmacology, Vol. 5, no. 3-4, 2005, pp. 164-168.
  106. Marinescu, D., Udriştoiu, T., Udriştoiu, I. – To Assess Suicidal Risk in Schizophrenia, Romanian Journal of Psychopharmacology, vol. 6, no. 1-2, 2006, Ed. Medical University of Craiova
  107. Marinescu, D., Bădescu, G., Udriştoiu, I., Mihăilă, Oana – Therapeutic Problems in the Posttraumatic Stress Disorder, Romanian Journal of Psychopharmacology, vol. 6, no. 1-2, 2006, Ed. Medical University of Craiova.
  108. Marinescu, D., Udriştoiu, T. – Neurobiological support and pharmacotherapy in bipolar disorder, Romanian Journal of Psychopharmacology, vol. 6, no. 3-4, 2006, Ed. Medical University of Craiova
  109. Marinescu, D. – Neurobiological Arguments for Early Treatment of Alzheimer’s Disease, Psihiatru.ro, Year III, No.8, March 2007, pp. 46-48.
  110. Marinescu, D. – The neurobiological support and the modern therapeutic perspective in bipolar disorder, Rev. Med. Chir. Shock. Med. Nat. Iaşi, 2007, vol. III, no. 2, Supplement no.2.
  111. Marinescu, D., Udriştoiu, T. – Neurobiological aspects in the diagnosis and therapy of Alzheimer’s disease, Romanian Journal of Psychopharmacology, no. 1-2, 2007
  112. Chimorgiachis, A., Marinescu, D. – Causes and management of antipsychotic-induced hyperprolactinemia, Romanian Journal of Psychopharmacology, no. 1-2, 2007

Marinescu, D., Udristoiu, T., Davidson, M., Camen, D., Udriştoiu, I., Marinescu, Ileana, Chimorgiachis, A. – The Vascular Factor in Schizophrenia and Neurobiological and Cardiac Vulnerability, Romanian Journal of Psychofarmacology, nr. 1, 2009

  1. Marinescu, D., Udristoiu, T., Udriştoiu, I., Marinescu, Ileana, Neurobiological arguments for a degenerative model in schizophrenia, Romanian Journal of Psychopharmacology, 2009, No. 2.
  2. Pânzaru, Corina, Marinescu, D. – Cognitive Functioning in Depressed People Treated with SSRI or TCA, Romanian Journal of Psychopharmacology, no. 4, 2009
  3. Khairi MHRA, Marinescu D, Chimorgiachis A, Marcean C – A Five Years Study of the Emergencies in the 1st Psychiatric Clinic of Craiova (1 January 2004 – 31 December 2008), Romanian Journal of Psychopharmacology, No 1, Year 2010
  4. Marinescu D, Pîrlog M – The Neurobiological and Social Dimension of Clinical Complexity and Integrative Diagnosis of Personality-Based Psychiatry, Bulletin of Integrative Psychiatry, Year XVI, Nr. 1 (44), 2010.
  5. Marinescu D, Udristoiu T, Marinescu I – Calcifications of the Choroid Plexus and Pineal Gland – Neurobiological Markers for Schizophrenia, Romanian Journal of Psychopharmacology, No 3, Year 2010
  6. Storyk O, Marinescu D – Efficiency of the Specific Treatment in the Correction of the Cognitive Deficit in Alzheimer’s Disease, Romanian Journal of Psychopharmacology, No 4, Year 2011
  7. Bratoi S, Marinescu D – Comparative study of the therapeutic effects of Atypicak and Typical Antipsychotics in the Treatment of Schizophrenia, Romanian Journal of Psychopharmacology, No. 1, Year 2012
  8. Storyk O, Marinescu D – Efficiency of Early Treatment in Correcting the Cognitive Deficit in Alzheimer’s Disease / Part 2, Romanian Journal of Psychopharmacology, No 2, Year 2012
  9. Marinescu D, Pîrlog M – Neurobiological Perspective in Autism and Autism Spectrum Disorders, Annals of the University of Oradea, Medical Fascicula, 8, 2012.
  10. Camen A, Marinescu D, Camen GC – 22q11 Deletion Syndrome – A Vulnerability for Cardiac Abnormalities and Psychotic Disorders: An Interdisciplinary Approach, Romanian Journal of Psychopharmacology, No 2, Year 2013
  11. Popescu C, Marinescu D – Grant me surcease from sorrow, Romanian Journal of Artistic Creativity, Spring 2013, Volume I, Number 1. pp. 27-36, ISSN 2327-5707.
  12. Marinescu I, Pîrlog M, Marinescu D. Clinical and Psychopharmacological Approach in the Perspective of the Complex Neurobiological and Social Model of Bipolar Disorders, Annals of the University of Oradea, Medical Fasc., Nr. 11-2014 and No. 12-2015, ISSN 1224-1245, pp-43-53.
  13. Mutica M, Marinescu I, Pirlog MC, Marinescu D, Untu I, Ciubara A. Characteristics of Cognitive Disorders in Schizophrenia and their Relation to the Social, Familial and Professional Adaptation Level. Revista de Cercetare si Interventie Sociala, 2015, 51, 56-63.
  14. Ileana Marinescu, A G Vîlcea, D Marinescu, Modele patogenice diferenţiate implicate în evoluţia defavorabilă a schizofreniei, Psihiatru.ro 2018; 52 (1):6-11, DOI: 10.26416/Psih.52.1.2018.1630 , ISSN 1841-4877, e-ISSN 2066-821X, ISSN-L 1841-4877
  15. E.N. Bondoc, Ileana Marinescu, D. Marinescu, Psychological and Biological Markers of the Suicidal Behavior in Post-Partum Depressive Disorder, Current Health Sciences Journal Vol. 45, No. 2, 2019 April-June   p 210-217  10.12865/CHSJ.45.02.13
  16. M Muntean, I Marinescu, D Marinescu, L Hogea, C Suru, VR Enătescu, Difficulties in functional recovery in schizophrenia: negative and cognitive symptoms. Psihiatru. Ro 54 (3), 2018
  17. EN Bondoc, I Marinescu, D Marinescu, Psychological and biological markers of the suicidal behavior in post-partum depressive disorder, 2019, Current health sciences journal 45 (2), 210
  18. I Marinescu, AG Vîlcea, D Marinescu, Modele patogenice diferenţiate implicate în evoluţia defavorabilă a schizofreniei, 2018, Psihiatru. ro 52.
  19. D Marinescu, T Udriştoiu, I Marinescu, Calcifications of the choroid plexus and pineal gland–neurobiological markers for schizophrenia, Romanian Journal of Psychopharmacology, 2010, 10, 129-136.

 

  1. ABSTRACTS PUBLISHED IN NATIONAL JOURNALS: 145

 

  1. EDUCATIONAL COURSES IN THE FIELD OF BIOLOGICAL PSYCHIATRY AND PSYCHO-PHARMACOLOGY ORGANIZED AT NATIONAL LEVEL (CAROL DAVILA BUCHAREST, CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN PSYCHIATRIC ASSOCIATION, BALINT ASSOCIATION):

1 The new standard of treatment in schizophrenia, January 15, 2005, Sinaia

2 The new standard of treatment in schizophrenia, January 29, 2005, Balvanyos

3 The new standard of treatment in schizophrenia, February 12, 2005, Moneasa

4 The new standard of treatment in schizophrenia, March 5, 2005, Sinaia

5 The new standard of treatment in schizophrenia, March 26, 2005, Vatra Dornei

6 Effective Dementia Management, March 31, 2005, Cluj-Napoca

7 Effective Management of Dementia, April 1, 2005, Brasov

8 Antipsychotics of the last generation in psychiatric practice, April 21, 2005, Timişoara

9 Effective Dementia Management, April 28, 2005, Constanta

10 Update in Schizophrenia Knowledge, May 7, 2005, Constanta

11 Antipsychotics of the last generation in psychiatric practice, May 2, 2005, Târgu Mureş

12 Antipsychotics of the last generation in psychiatric practice, June 10, 2005, Constanta

13 Antipsychotics of the last generation in psychiatric practice, June 17, 2005, Iasi

14 Antipsychotics of the last generation in psychiatric practice, July 8, 2005, Craiova.

15 Fundamental Elements of Clinical Psychopharmacology 10-12 August 2006, Craiova

16 Therapeutic strategies in bipolar disorder December 5, 2006, Craiova

17 Somatopsychological correlations in the evolution of depressive disorders, January 27, 2007, Craiova;

18 The role of family doctors in early detection of dementia disorders. Prodromal syndromes in dementia, February 9, 2007, Craiova;

19 Elements of therapeutic management in anxiety and depressive disorders, February 22, 2007;

20 Therapeutic strategies and safety in administration of atypical antipsychotics, March 30, 2007;

21 Fundamental elements of clinical psychopharmacology, neurobiology and neurobiochemistry; June 28-30, 2007, Craiova, The First National Symposium of Biological Psychiatry.

22 Current psycho-pharmacological and neurobiological outlook for depressive disorder November 14, 2007, Craiova

23 The present psychopharmacological and neurobiological perspective in depressive disorder May 23, 2008, Timişoara

24 Neurobiological support of behavioral disorders and psychotic manifestations of Alzheimer’s disease June 13, 2008, Craiova, National Congress of Biological Psychiatry

25 Neurobiological Support and Current Therapeutic Pharmacological Outlook in Bipolar Disorder June 13, 2008, Craiova, National Congress of Biological Psychiatry

26 Therapeutic strategies in major depressive disorder with dopamine deficiency; June 20, 2008;

Current elements in the neurobiology of schizophrenia and bipolar disorder; 23-27 June 2008;

Recent elements of neurobiology and therapeutic management in dementia; June 30 – July 4, 2008;

29 Therapeutic strategies in dopaminergic depression October 1, 2008, National Conference of Psychiatry, Bucharest

30 Etiopatogenic, Neurobiological and Psychopharmacological Arguments in the Major Depression Therapeutic Strategies. 10-14 nov. 2008, Craiova

31 Perspective of early diagnosis and monitoring in major psychiatric disorders at family doctor level; November 20-23, 2008.

32 Neurobiological and Clinical Arguments in Treatment with Atypical Antipsychotics – Focus Aripiprazole – February 13, 2009

33 Neurobiological support in the therapeutic strategies of depression and anxiety – 26 March 2009, National Conference on Biological Psychiatry Craiova

34 Neurobiological Support in Therapeutic Strategies in Schizophrenia – March 26, 2009, National Biological Psychiatry Conference Craiova

35 Bipolar affective disorders. April 22, 2009, National Congress of Residents in Psychiatry Timisoara

36 Fundamental elements of clinical psychopharmacology – dopamine in psychiatric and neurological pathology. September 18 – 19, 2009, Craiova

Psychopharmacological and neurobiological facts in the treatment of schizophrenia. October 15 – 16, 2009, Craiova

38 Current Management of the Psychiatric Patient: From Neurobiochemistry, to the Patient’s Bed – Neurological and Clinical Arguments in Treatment with Atypical Antipsychotics, November 27, 2009, Craiovas

39 Neuroprotection in major psychiatric disorders. February 19, 2010, Craiova

Neurobiological facts in the treatment of depressive disorder. March 25, 2010, National Conference on Biological Psychology, Craiova.

Neurobiological facts in the treatment of Alzheimer’s disease. March 25, 2010, National Conference on Biological Psychology, Craiova.

Neurobiological bases of antipsychotic treatment in schizophrenia. March 25, 2010, National Conference on Biological Psychology, Craiova.

43 Neurobiological and Psychopharmacological Fundamentals of Antipsychotic Therapy in Schizophrenia. May 6, 2010, Timisoara.

Neurobiological bases of current therapeutic strategies in Alzheimer’s disease. 7-8 May 2010, Craiova

Neurobiological News in the Therapeutic Management of Depressive Disorder. May 14, 2010, Craiova

46 The cellular mechanisms involved in the inter-episodic stability of bipolar disorders, 3rd French-Romanian Psychiatric Meeting, 14-16 October 2010, Sibiu.

47 Concept of Adherence to Treatment in the Perspective of Biological Psychiatry, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, March 30 – April 2, 2011

48 Main neurotransmitters involved in psychiatric pathology, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, 30 March – 2 April 2011

49 Principles of Clinical Psychopharmacology, National Conference of Biological Psychiatry and Psychopharmacology with International Participation, Craiova, March 30 – April 2, 2011

50 The Biological Concept of MCI Siondroma – Early Treatment of Alzheimer’s Disease, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, 30 March – 2 April 2011

51 Biological Psychology and Depression, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, March 30 – April 2, 2011

Neurobiological Arguments in Optimizing the Treatment of Alzheimer’s Disease, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, 30 March – 2 April 2011

53 Neurobiological Models of Depression, National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, 30 March – 2 April 2011

Manic access between anthropology and biological psychiatry (workshop), National Conference on Biological Psychiatry and Psychopharmacology with International Participation, Craiova, 30 March – 2 April 2011

55 Psychopharmacology of TBII, National Conference of Biological Psychiatry and Psychopharmacology with International Participation, Craiova, March 30 – April 2, 2011

56 Antipsychotic and Biological Psychiatry, National Conference of Biological Psychiatry and Psychopharmacology with International Participation, Craiova, March 30 – April 2, 2011

57 Vascular Factor in MCI Syndrome in Alzheimer’s Disease, Psychiatric Area Symposium “The First Psychosis Episode”, Timişoara 26-28 May 2011

58 News in neurobiology of depression, Psychiatric Zone Symposium “First episode of psychosis”, Timişoara 26-28 May 2011

59 Atypical antipsychotics with prolonged action from the perspective of biological psychiatry, Psychiatric Zone Symposium “The first psychosis episode”, Timişoara 26-28 May 2011

60 Psychopharmacology of Depression, June 23, 2011, Târgu Mureş, VIth National Symposium of Psychiatry with International Participation “Actualities and Prospects in the Knowledge and Treatment of Depressive Disorder Disorders”

61 The Role of Family Physician in Early Diagnosis and Assistance to Patients with Psychiatric Disorders, Summer Course addressed to family physicians and physicians residing in psychiatry, Craiova, 14-15 July 2011

62 Clinical News, Treatment and Neurobiology of Depressive Disorders, Educational Course Craiova, August – September 2011

63 Neurobiological News in Autism Spectrum Disorders, September 7, 2011, Oradea.

64 Actualities in the Recognition and Treatment of Depression, XVIIIth Balint National Conference, Sfîntu-Gheorghe, Hotel Sugás, September 23-25, 2011

65 Neurobiological support in the evolutionary stages of Alzheimer’s disease, 4th National Congress of Psychiatry with International Participation, Bucharest, 19 October 2011.

66 Neurobiological bases of antipsychotic treatment, 4th National Congress of Psychiatry with International Participation, Bucharest, 19 October 2011.

67 Cardinale Highlights in Psychiatry, Symposium Satelin Janssen, 4th National Congress of Psychiatry with International Participation, Bucharest, October 20, 2011.

68 The first national training project (educational course – workshop) addressed to young psychiatrists. Biological Basics of Clinical Psychopharmacology in Major Psychiatric Disorders, Craiova, 24-26 November 2011

69 Actualities in the Diagnosis and Early Treatment of Depression and Alzheimer’s Disease, Craiova, Psychiatry Clinic I, April 11, 2012.

70 Educational course addressed to young psychiatrists, Depressive disorder between the biological and the psychotherapeutic slope, Craiova, 24-25 February 2012.

Neurobiology and psychopharmacology of the first episode of major psychiatric disorders. Clinical-therapeutic correlations. Craiova, National Conference of Biological Psychiatry and Psychopharmacology, March 28-31, 2012.

Clinical and psychopharmacological correlations in major psychiatric disorders. Craiova, National Conference of Biological Psychiatry and Psychopharmacology, March 28-31, 2012.

73 Actualities in the Diagnosis and Early Treatment of Alzheimer’s Depression and Disease, Craiova, April 11, 2012.

74 Summer Educational Course for Young Psychiatrists, Somatic and Psychiatric Comorbidities in Major Psychiatric Disorders, Craiova, 28-29 June 2012.

75 Educational Course – Cardiometabolic Risks vs. Antipsychotic therapy – A psychiatric review, 25 th Danube Symposium of Psychiatry, Timişoara, September 26-29, 2012.

76 Presentation of the training curriculum in the field of the application of the new legislative regulations on the assessment of work capacity (GAF) and the training of professionals working in the mental health system. Course organized by the Romanian League of Mental Health and the Ministry of Health, National Conference of Psychiatry with International Participation Evidence and Values ​​in Contemporary Psychiatry. Socola School – 107 years of psychiatry. Iasi, 4-7 October 2012

77 Problems of early diagnosis in schizophrenia, neurobiological, clinical and therapeutic elements. National Conference of Psychiatry with International Participation Evidence and Values ​​in Contemporary Psychiatry. Socola School – 107 years of psychiatry. Iasi, 4-7 October 2012.

78 Module “Labor Capacity Assessment for Mental Health Professionals – GAF Instrument” and Module “Toxicomania” Clinical Neuropsychiatry Hospital Craiova, Dolj County, 25 October 2012, Project financed by the National Health Mental Health Program of the Ministry of Health 2012 .

Clinical, neurobiological and psychopharmacological correlations in the treatment of depressive disorders. Unilateral and bipolar depressive disorder. The report of comorbidity depressive disorder – anxiety. Regional Educational Symposium “Diagnosis and Pharmacological Treatment of Major Psychiatric Disorders” Psychiatric Clinic I, Craiova, 14 – 15 February 2013

Clinical Pharmacology of Antidepressants. Regional Educational Symposium “Diagnosis and Pharmacological Treatment of Major Psychiatric Disorders” Psychiatric Clinic I, Craiova, 14 – 15 February 2013

81 Clinical and Neurobiological Basics of Early Diagnosis and Antipsychotic Therapy. Regional Educational Symposium “Diagnosis and Pharmacological Treatment of Major Psychiatric Disorders” Psychiatric Clinic I, Craiova, 14 – 15 February 2013

Clinical Pharmacology of Antipsychotics. Adherence and therapeutic efficacy for innovative pharmacological formulations of antipsychotics. Regional Educational Symposium “Diagnosis and Pharmacological Treatment of Major Psychiatric Disorders” Psychiatric Clinic I, Craiova, 14 – 15 February 2013

83 Anti-dementia medication. The role of neurobiological evaluations in the evolution of Alzheimer’s disease. Regional Educational Symposium “Diagnosis and Pharmacological Treatment of Major Psychiatric Disorders” Psychiatric Clinic I, Craiova, 14 – 15 February 2013

84 Optimization of therapeutic strategies based on clinical-neuroanatomic correlations in schizophrenia. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

Tripartite synapse in neurobiology of depressive disorder. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

86 Extrapyramidal symptoms of schizophrenia and depressive disorder – predictors of cognitive impairment. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

87 Prolonged-action antipsychotic drugs – particular psychopharmacological mechanisms for adherence and treatment compliance. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

Neurobiological arguments for antipsychotic therapy in the onset of schizophrenia. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

89 Principles of clinical psychopharmacology in the treatment of depressive disorder. National Conference of Biological Psychology and Psychopharmacology – with international participation – Craiova 20-23 March 2013.

90 Updates in MDD Psychopharmacology: the benefits of synergic ways of action. WPA Regional Congress, Bucharest, Romania, 10-13 April 2013.

91 The Pathological Importance of Alcoholic Comorbidity in Psychiatry – The 3rd Congress on Psychiatric Scientific Research in Romania, Oradea, 6-8 June 2013.

92 Current Targets and Traps of Antipsychotic Treatment – Janssen National Symposium, Multidisciplinary Approach to Patients with Severe Mental Disorders, Bucharest, May 24, 2013.

93 Neurotrophic Factors in the Age of Molecular Biology – Role and Mechanism of Action in Dementia Therapy, Workshop New neurobiological concepts, neuroprotection and neurogeneration. Neuropharmacology of multimodal molecules, Craiova, June 13, 2013.

94 Pathology of Biological Rhythms and Depression from the Perspective of Biological Psychiatry, 19th National Symposium RPNES, Subclinical Psychoneuroendocrine Pathology. Neuroendocrinology of rhythms, May 30 – June 1, 2013, Sibiu.

95 Neurobiological, Psychopharmacological and Clinical Arguments on Alcohol-Based Therapeutic and Preventive Strategies – Round Table “National Mental Health Program – Priorities 2013 – 2104” Event organized by the National Center for Mental Health and Anti-Drug in the context of May 2013 – Month of Health Mental, Bucharest, May 29, 2013.

96 Neurobiological Arguments for Preventive Anticravigation Strategies in Treating Alcohol Dependence, Lundbeck Symposium, Murighiol, June 13-16, 2013.

97 The Benefits of Synergic Mechanisms and the New Approach to Depression from the Psychopharmacological Perspective, Symposium “The New Approach to Depression from a Clinical and Psychopharmacological Perspective”, VIth National Symposium of Psychiatry with International Participation “Actualities and Perspectives in the Knowledge and Treatment of Type Disorders Disorders Depression “Târgu-Mureş, 19-21 June 2013.

98 Seroquel XR – Innovative Formula, Improved Performance, VIth National Symposium of Psychiatry with International Participation “Actualities and Perspectives in the Knowledge and Treatment of Depressive Disorder Disorders” Târgu-Mureş, 19-21 June 2013.

99 New Psychopharmacological and Neurobiological Perspectives in the Treatment of Depression – Alcoholism, VIth National Symposium of Psychiatry with International Participation “Actualities and Perspectives in the Knowledge and Treatment of Depressive Disorder Disorders” Târgu-Mureş, 19-21 June 2013.

100 Psychopharmacological mechanisms of antipsychotic substances and adherence to treatment and social recovery in various stages of evolution of schizophrenia, National Conference Psychosocial rehabilitation between vision and achievement, Association of Social Psychiatry in Romania, Romanian Association for Psychosocial Rehabilitation, Câmpulung Moldovenesc, 7- July 14, 2013.

101 New Therapeutic Strategies in Addressing the Depressive Disorder – Benefits in Functional and Social Recovery, National Conference Psychosocial Rehabilitation Between Vision and Achievement, Association of Social Psychiatry of Romania, Romanian Association for Psychosocial Rehabilitation, Câmpulung Moldovenesc, 7-14 July 2013.

102 Anti-craving medication – the therapeutic and destigmatism of the patient with alcoholic dependence, National Conference Psycho-social rehabilitation between vision and achievement, Association of Social Psychiatry in Romania, Romanian Association for Psychosocial Rehabilitation, Câmpulung Moldovenesc, 7-14 July 2013.

103 Nalmefene – Pharmacological Profile, Expert Meeting on Alcohol Dependence, Braşov, September 6-8, 2013.

104 The need for new antidepressant drugs – a clinical reality based on synergic etiopathogenic mechanisms, Zonal Symposium of Psychiatry, Timisoara 17-19 October 2013

105 Psychopharmacology of antipsychotics with action taken – differences in mechanisms of action of first and second generation antipsychotics, Psychiatric Area Symposium, Timisoara 17-19 October 2013.

106 The glutamatergic mechanisms and the role of NMDA receptors in cognitive deficits in various psychiatric disorders, Mirvedol – A Possible Therapeutic Behavior?, Bucharest, February 7, 2014

107 Neurobiological and psychopharmacological models of psychomotor agitation in patients with schizophrenia and bipolar disorder, Galenica event, Poiana Braşov, February 22, 2014

108 Clinical, neurobiological and therapeutic updates in the pathology of alcohol dependence. Educational Course: Comorbidity of Alcoholic Addiction – Evolutionary Risk Factor in Major Psychiatric Disorders, Craiova, January 30, 2014.

109 Nalmefene pharmacological profile, Lundbeck Event, Bucharest, March 1, 2014.

Prolonged antipsychotic medication – psychopharmacological and neurobiological news in the therapy of schizophrenia. National Conference with International Participation in Biological Psychiatry and Psychopharmacology, Tuesday, March 25, 2014, Educational Course of Biological Psychology and Psychopharmacology for Young Physicians and Researchers.

111 New Neuro-Biological Perspective of Depression, Synergistic Mechanisms in the Current Therapeutic Approach. National Conference with International Participation in Biological Psychiatry and Psychopharmacology, Tuesday, March 25, 2014, Educational Course of Biological Psychology and Psychopharmacology for Young Physicians and Researchers.

112 Identification of clinical, evolutionary and neurobiological risk factors for incomplete therapeutic response for bipolar depression. National Conference with International Participation in Biological Psychiatry and Psychopharmacology, Tuesday, March 25, 2014, Educational Course of Biological Psychology and Psychopharmacology for Young Physicians and Researchers.

Glutamatergic mechanisms in dementia; cognitive and neuropsychiatric manifestations in neurodegenerative diseases and rare forms of dementia. National Conference with International Participation in Biological Psychiatry and Psychopharmacology, Tuesday, March 25, 2014, Educational Course of Biological Psychology and Psychopharmacology for Young Physicians and Researchers.

Neurobiological Perspective of Cognitive Damage Consequent to Infectious Processes; particular aspects of clinical psychopharmacology of antibiotic, antiviral and antifungal substances. National Conference with International Participation in Biological Psychiatry and Psychopharmacology, Tuesday, March 25, 2014, Educational Course of Biological Psychology and Psychopharmacology for Young Physicians and Researchers.

115 Alcohol dependence – a new therapeutic approach. Course held under the aegis of the Academy of Medical Sciences – Craiova Branch, National Conference with International Participation in Biological Psychology and Psychopharmacology, Wednesday, March 26, 2014, Educational Course of the Romanian Society of Biological Psychology and Psychopharmacology.

116 Therapeutic strategies in the model of multisystemic pathology of depression, National Conference with International Participation of Biological Psychology and Psychopharmacology, Wednesday, March 26, 2014, Educational Course of the Romanian Society of Biological Psychology and Psychopharmacology.

117 Biological indicators in early diagnosis and prediction of therapeutic response in schizophrenia and bipolar disorder. National Conference with International Participation in Biological Psychology and Psychopharmacology, Wednesday, March 26, 2014, Educational Course of the Romanian Society of Biological Psychology and Psychopharmacology.

118 Beyond Positive Symptoms in Schizophrenia, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, March 26-29, 2014

119 Innovative Psychopharmacological Approaches in the Treatment of Depression, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, March 26-29, 2014

120 A New Approach to Alcoholism Based on Neurobiological Models – Focus Opioid Receptors, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, March 26-29, 2014

121 Neurobiology of affective disorders in the clinic, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, March 26-29, 2014

122 Re-evaluation of Dopaminergic Mechanisms in Schizophrenia Therapy – The Role of Dopaminergic Modulators, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, March 26-29, 2014

123 Actualities in neurobiology and psychopharmacology of depression. The role of synergistic mechanisms. Servier Event, Bucharest, May 9, 2014.

124 Management of bipolar affective disorder in the clinic. Relevant aspects for a favorable prognosis. Astra Zeneca event, Bucharest, May 14, 2014.

125 Actualities in neurobiology and psychopharmacology of depression. The role of synergistic mechanisms. Servier Event, Oradea, May 15, 2014.

126 Neurobiological Evidence of Continuous Treatment in Schizophrenia. National Symposium of Psychiatry “The Benefits of Long-Term Continuous Treatment in Schizophrenia” Snagov Conference Center May 23, 2014

The risk of psychomotor agitation in the development and treatment of personality disorders associated with schizophrenia and bipolar disorder. XIIth National Symposium of the Romanian Association for the Study of Personality, Sibiu, May 29 – June 1, 2014.

128 Neurobiological facts in the treatment of depression. XIIth National Symposium of the Romanian Association for the Study of Personality, Sibiu, May 29 – June 1, 2014.

129 Biological, Psychopharmacological and Psychosocial Arguments for a New Approach to Alcohol Therapy. XIIth National Symposium of the Romanian Association for the Study of Personality, Sibiu, May 29 – June 1, 2014.

130 Neurobiological and Psychopharmacological Arguments for the New Drug Strategies in the Depressive Disorder, APT Symposium for Psychiatric Symposium, Timisoara, 24-25 April 2014

131 Neurobiological and Psychopharmacological Arguments for the New Drug Strategies in the Depressive Disorder, APT Symposium for Psychiatric Symposium, Timisoara, 24-25 April 2014

132 Actualities in neurobiology of depression, APT Symposium of Psychiatric Symposium, Timisoara, April 24-25, 2014.

133 How and when we use antipsychotic treatment: Biological and psychopharmacological models of psychotic disorders, VIIth International Conference on Romanian-Hungarian Psychiatry, 26-29 June 2014, Miercurea Ciuc

Neurobiological models in major depressive disorder. The role of innovative therapies. Multisystemic Disease Depression Symposium “Biological Basics and Clinical Psychopharmacology in Affective, Deterioration-Dementia, Addiction and Schizophrenia Disorders”, Craiova, September 8 – 10, 2014

Neurobiological mechanisms with therapeutic benefits in the treatment of affective disorders in schizophrenia with prolonged antipsychotic substances, Symposium “Biological Basics and Clinical Psychopharmacology in Affective Disorders, Deterioration-Dementia, Addiction and Schizophrenia” Craiova, 8-10 September 2014

136 Differentiated Neurobiological Mechanisms in Type I and II Bipolar Disorders, Symposium “Biological Basics and Clinical Psychopharmacology in Affective, Deterioration-Dementia, Addiction and Schizophrenia Disorders” Craiova, September 8 – 10, 2014

137 Addition to alcohol in prodromal phases of dementia. The role of preventive therapeutic strategies. Symposium “Biological Basics and Clinical Psychopharmacology in Affective, Deterioration-Dementia, Addiction and Schizophrenia Disorders” Craiova, 8-10 September 2014

138 Preventive strategies for alcohol dependence based on opioid mechanisms Symposium “Biological basics and clinical psychopharmacology in emotional, dementia-demential, addictive and schizophrenic disorders” Craiova, 8-10 September 2014

139 New Technologies in Research, Diagnosis and Psychiatric Care in the Digital Age. Biological and Fundamental Research in Psychiatry: Depression and Neurohormones AMRPR Congress 2014, 03 – 05 September 2014, Hotel Ibis Palace of Parliament, Bucharest

140 When and how do we use prolonged action injections of antipsychotics in schizophrenia therapy? Congress AMRPR 2014, 03 – 05 September 2014, Hotel Ibis Palace of Parliament, Bucharest

141 Neurobiological models of psychomotor agitation in schizophrenia and bipolar disorder vs. neurological models. therapeutic attitude The 5 th National Congress of Psychiatry, 08 – 11 October 2014, International Conference Center, Sinaia

142 Prolonged-acting antipsychotic medication used at the onset of schizophrenia – efficacy, risks, benefits The 5th National Congress of Psychiatry, 08-11 October 2014, the International Conference Center, Sinaia

143 The biological bases of the new psychopharmacological models in depressive disorder The 5th National Congress of Psychiatry, 08 – 11 October 2014, International Conference Center, Sinaia

Clinical and Biological Markers for Predicting the Risk Potential for Schizophrenia in Children and Adolescents, National Conference on Child and Adolescent Psychiatry, Bucharest, November 7, 2014

145 Challenges of Antidepressant Treatment in Patients with Associated Cardiovascular Diseases, Forum Psihiatru.ro, V-Edition, Breaking News: Psychiatry, 8 November 2014

146 News in Psycho-Pharmacological Therapy of Schizophrenia, Forum Psihiatru.ro, V-Edition, Breaking News: Psychiatry, November 8, 2014

147 Synergistic mechanisms of antidepressants and therapeutic benefit. Psychopharmacological and Clinical News in Major Psychiatric Pathology, Craiova, December 18, 2014

148 Strategies of therapeutic switch to aripiprazole with prolonged action. Psychopharmacological and Clinical News in Major Psychiatric Pathology, Craiova, December 18, 2014

149 Neuroprotection – an essential factor in cognitive preservation of depressive disorders. Psychopharmacological and Clinical News in Major Psychiatric Pathology, Craiova, December 18, 2014

150 Biological markers of early diagnosis in Alzheimer’s disease. Neural Ratio – Glial System in Early Therapeutic Strategies, Expert Meeting “Early Diagnosis of Alzheimer’s Disease”, February 25, 2015, Bucharest

151 Neurobiological Mechanisms and Therapeutic Action of Timostabilizers in Major Psychiatric Disorders, National Conference with International Participation in Biological Psychology and Psychopharmacology, 18-21 March 2015

152 The differences between the princeps substance and the active metabolite in the LAI psychopharmacology (risperdone vs. paliperidone), National Conference with International Participation in Biological Psychology and Psychopharmacology, 18-21 March 2015

153 Synergistic Mechanisms in the Ethiopathy of Depressive Disorder, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

154 Psychopharmacology of quetiapine XR and pharmaco-biological correlations in etiopathogenesis and treatment of bipolar depression, National Conference with International Participation of Biological Psychiatry and Psychopharmacology, 18-21 March 2015

155 Infectious Factors in the Ethiopathy of Major Psychiatric Disorders, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

156 Early diagnosis of deterioration-dementia disorders. Clinical Evidence vs. Biological indicators. Neural Ratio – Glial System in Early Therapeutic Strategies, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

Neuroprotection 157. Neurogenesis vs. Disconetivity and Metaconactivity in major psychiatric disorders

158 Current Perspectives in the Etiopathogenesis of Schizophrenia, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

159 Etiopathogenic and pharmacological correlations of psychomotor agitation and aggression in schizophrenia and bipolar disorder, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

160 Possibilities to Prevent Neurobiological Risks from Pediatric Surgery Supported by Evidence on Animal Model, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

161 Opioid Mechanisms in Primary and Dual Alcohol Therapy, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

162 Paliperidone Palmitate: Benefits of Monthly Administration in Schizophrenic Patients, National Conference with International Biological Psychiatric Participation and Psychopharmacology, 18-21 March 2015

163 Particularities of Bipolar Affective Disorder Management. Relevant elements for a favorable prognosis, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

164 Actualities in major depressive episode management, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

165 Therapeutic Management in Schizophrenia. Optimization of long-term outcomes, National Conference with International Participation in Biological Psychology and Psychopharmacology, 18-21 March 2015

166 Protective opportunities for the functionality of patients with schizophrenia. The role of extended-realease aripiprazole, National Conference with International Participation in Biological Psychiatry and Psychopharmacology, 18-21 March 2015

167 Primary Prevention Elements of Schizophrenia Disorders, Medic.ro Conference, Craiova, April 28, 2015

168 Neurobiological and Psychopharmacological Basics of Antisocial Behavior in Schizophrenia, XIIIth National Symposium of the Romanian Association for the Study of Personality, Alba Iulia, 23-26 April 2015

169 Etiopathogenic and pharmacological correlations of psychomotor agitation and aggression in schizophrenia, bipolar disorder and depression, XIIIth National Symposium of the Romanian Association for the Study of Personality, Alba Iulia, 23-26 April 2015

Neurobiological and psychopharmacological particular mechanisms of aripiprazole treatment with prolonged action in schizophrenia. Reducing the antisocial problems represented by the residual personality disorders and dual pathology, the 13th National Symposium of the Romanian Association for the Study of Personality, Alba Iulia, 23-26 April 2015

171 The Difference in the Treatment of Cardiovascularly Depressed Patients, Medic.ro Conference, Craiova, April 28, 2015

172 Neurological Perspective on the Benefits of Prolonged Action Injection Antipsychotics, National Symposium of Psychiatry, Destination: Remission and Recovery. Current Objectives in the Treatment of Schizophrenia, Bucharest, May 8, 2015.

173 The Neurobiological Model of Bipolar Depression and Real Therapeutics, National Conference on Bipolar Disorders and Related Suffrations, Oradea, 21-23 May 2015

174 Synergistic Mechanisms in Neurobiology and Psychopharmacology of Depression, National Conference on Bipolar Disorders and Related Suffrations, Oradea, 21-23 May 2015

175 Psychomotor agitation – a behavioral risk factor in bipolar disorder. Therapeutic role of immediate-acting antipsychotic drugs and therapeutic strategies based on first and second-generation LAI antipsychotics, National Conference on Bipolar Disorders and Related Suffocation, Oradea, 21-23 May 2015

176 Actualities in Depression Neurobiology, VIIth National Symposium of Psychiatry with International Participation “Actualities and Prospects in the Knowledge and Treatment of Depressive Disorder Disorders” 4 – 7 June 2015, Tîrgu-Mureş

177 Current Perspective in Psychopharmacology of Schizophrenia, New Biological Models and Development of Different Therapeutic Strategies. Current Perspective in Psychopharmacology of Schizophrenia, Bucharest, June 10, 2015.

178 Current Perspective in Psychopharmacology of Schizophrenia, New Biological Models and Development of Differential Therapeutic Strategies. Current Perspective in the Psychopharmacology of Schizophrenia, Craiova, June 17, 2015.

179 Biological and Psychopharmacological Mechanisms in LAI Therapies for Functional Recovery, Conference The Role of Community Psychiatry in Forensic Psychiatry, Câmpulung Moldovenesc, 2 – 4 July, 2015

180 Dopaminergic modulators – innovative antipsychotic substances in the pharmacological concept of long-term therapies in schizophrenia, Conference “The Role of Community Psychiatry in Forensic Psychiatry”, Câmpulung Moldovenesc, 2-4 July, 2015

181 Extrapyramidal phenomena and hyperprolactinaemia induced by antipsychotic medication – predictive factors of antisocial manifestations in patients with schizophrenia and bipolar disorder. The Value of Switching Strategies, Conference “The Role of Community Psychiatry in Forensic Psychiatry”, Câmpulung Moldovenesc, 2-4 July, 2015

182 Current neurobiological models of depression (melatoninergic model) vs. neuron / astroglie report – National Symposium with International Participation, Timisoara 9-11 September 2015

183 Etiopathogenic support of antipsychotic psychopharmacological strategies based on LAI substances – National Symposium with International Participation, Timisoara 9-11 September 2015

184 Current neurobiological models of depression (melatoninergic model) vs. neuron / astroglie report – National Symposium with International Participation, Timisoara 9-11 September 2015

185 From current neurobiological models to interventional and observational studies – AMRPR National Congress, Timisoara 11-13 September 2015

When ingestion of prolonged-action injections of antipsychotics (Focus paliperidone) is given. Individualization of treatment according to clinical and neurobiological models – AMRPR National Congress, Timisoara 11-13 September 2015

 

  1. EDUCATIONAL PROJECTS AND CONTINUING EDUCATION

1.Marinescu D, Marinescu I, Pîrlog M. Actualităţi biologice în tratamentul medicamentos al tulburării depresive, http://www.cursurimedicale.ro/cursuri. (18 credite EMC, conform Adresei 6174/09.10.2014)

2.Curs organizate de UMF Craiova şi Autoritatea Naţională de Management al Calităţii în Sănătate (ANMCS), şi Academia de Ştiinţe Medicale din România “Riscurile clinice asociate medicatiei psihotrope si efectele adverse induse de medicatia non psihotropa utilizatain asistenta medicala psihiatrica”, coordonat de Acad. Prof. Univ. Dr. Dragoș Marinescu,iunie- iulie 2020, 19 credite EMC.

3.Curs organizate de UMF Craiova şi Autoritatea Naţională de Management al Calităţii în Sănătate (ANMCS), şi Academia de Ştiinţe Medicale din România, “Ininfectiile in sarcina – factori de risc matern, neonatal si psihiatric, septembrie 2020, 19 credite EMC.

 

  1. CONGRESSES AND SCIENTIFIC MEETINGS DURING 2018 – PRESENT
  2. Ileana Marinescu, D. Marinescu, L. Mogoantă, Corelații histopatologice, neurobiologice și clinice al rolului traumatismelor cerebrale minore în declinul cognitiv rapid al pacienților cu boala Alzheimer la vârstă înaintată , Al XVI-lea Simpozion Naţional de Morfologie Microscopică cu participare internaţională volum de rezumate, Craiova 23-26 mai 2018,Ed. Sitech Craiova, Romania, p. 47-48, ISBN 978-606-11-6421-9
  3. Ileana Marinescu, P. O. Stovicek, D. Marinescu – Blood-Brain Barrier Disruption – a Risk Factor in the Evolution of Alzheimer’s Disease -Conferința Națională Alzheimer 2018 Ediția a 8-a, Actualități în domeniul demențelor www.alzcongres.ro, Scientific Abstract book, Vol VIII, 2018, Editia VIII, p. 36,  ISSN 2601-4017 , ISSN-L 2601-4017
  4. D. Marinescu, Ileana Marinescu, P. O. Stovicek, Ramona Adriana Schenker, Argumente neuropsihologice, psihofarmacologice și clinice pentru abordarea depresiei din oncologie / Neuropsychological, Psychofarmacological and Clinical Arguments to Approach Depression in Oncology; Simpozion in cadrul Conferinta Nationala de psihiatrie ed a XII-a, 16-19 mai 2018, Timisoara, Revista romana de psihiatrie Vol XX, nr 1, p-ISSN 1454-7848, e-ISSN 2068-7176, pg 71
  5. Ileana Marinescu, D. Marinescu, D.G. Mălăescu, Ramona Adriana Schenker, P.O. Stovicek, Traumatismele craniene minore și disfuncția axonală – factori de risc ai deteriorării cognitive rapide în boala Alzheimer / Minor Head Trauma and Axonal Injury – Risk Factors of Cognitive Deterioration in Alzheimer’s Disease, Conferinta Nationala de psihiatrie ed a XII-a, 16-19 mai 2018, Timisoara, Revista romana de psihiatrie Vol XX, nr 1, supplement 1, aprilie 2018 p-ISSN 1454-7848, e-ISSN 2068-7176, pg 105
  6. Ileana Marinescu, D Marinescu, Denisa Floriana Vasilica Pirșcoveanu, P O Stovicek, Sindromul extrapiramidal – marker al evoluției nefavorabile de tip neurodegenerativ în schizofrenie / Extrapiramidal Syndrome – Marker of Unfavorable Neurodegenerative Evolution in Schizophrenia, Conferinta Nationala de psihiatrie ed a XII-a, 16-19 mai 2018, Timisoara, Revista romana de psihiatrie Vol XX, nr 1, supplement 1, aprilie 2018 p-ISSN 1454-7848, e-ISSN 2068-7176, pg 105
  7. T Udristoiu, D Marinescu, Ileana Marinescu, Extrapyramidal symptoms in schizophrenia – potential marker for the neurodegenerative course, A XI-A Conferinta Nationala de psihologie si psihofarmacologie Craiova, 18-21 aprilie 2018 Revista romana de psihiatrie Vol XX, nr 1, martie 2018, p-ISSN: 1454-7848 e-ISSN: 2068-7176, p. 2
  8. Dragoș Marinescu, Ileana Marinescu, Puiu Olivian Stovicek, Acceptance of biological models in clinical psychopharmacology – major opportunity of psychosocial rehabilitation and improvement of specific management of major psychiatric disorders, Conference “The psychiatrist’s role in increasing the quality of patient’s life and psychosocial rehabilitation”, 19 – 22 September 2019, Tîrgu Mureș, Romania, Acta Medica Marisiensis, Volume 65|Supplement 8 2019, ISSN: 2068 – 3324, Online ISSN: 2247-6113
  9. Puiu Olivian Stovicek, Dragoș Marinescu, Ileana Marinescu, Prodromed Depression of the Elderly – a Risk Factor for Cognitive Impairment in Alzheimer’s Disease, National Alzheimer Conference 2019, 9th Edition, Latest Dementia News, ISSN 2601-4017, ISSN-L 2601-4017.
  10. Dragos Marinescu, Laurentiu Mogoanta, Carol Friedman, Olivian Stovicek, Ileana Marinescu, Potential markers of the rapid cognitive decline consecutive of minor brain injuries- the translational perspective, ACADEMICIAN NICOLAE CAJAL SYMPOSIUM, XIV edition, OCTOBER 17 – 19, 2019, Bucharest
  11. Ileana Marinescu, Puiu Olivian Stovicek, Dragoș Marinescu, Blood-brain barier barrier disruption – a risk factor in the evolution of Alzheiner disease, volum rezumate Conferința Națională Alzheimer, 2018, București
Share This Speaker
Leave a Comment

Speaker Details
Events of the Speaker
You might also love these events.
Ozonetherapy conference 2022 Romania – Bucharest
May 5, 2022
Expired
Related Speakers
You might also love these speakers.
PhD Olga Sonia León Fernández
PhD in Biochemistry and Biological Sciences
PhD in Biochemistry and Biological Sciences, Havana University, Cuba. More than 30 years research in diseases of oxidative etiology.  More than 25 years research and teaching in pharmacology of medical ozone.  Award of the Cuban Academy of Sciences, Awards of Havana University and the Society of Cuban Pharmacology
Dr. Silvia Menéndez Cepero
Ph.D. in Chemical Sciences
Former Director of the Ozone Clinic of the National Center for Scientific Research (CNIC) of Cuba
Prof. Dr. Med. Ziad Fahmy
M.CH.B, MD, D.Ph. Med. PH. D
Professor of reumathology Chief Consulting Rheumatologist Augusta Clinic, Bad Kreuznach

Acest site foloseşte cookies pentru a imbunatati experienta ta de navigare. Pentru mai multe detalii referitoare la cum folosim datele tale si la drepturile voastra va invitam sa citesti Politica de cookies.

Accept